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vivo	 application	 of	 the	 recombinases	 for	 chassis	 optimization	 for	 heterologous	
pathway	expression	in	synthetic	yeast	and	 in	vitro	application	of	recombinases	for	
gene	expression	optimization.		
For	 in	 vivo	 application,	 two	 recombination	 systems,	 Cre/loxP	 and	 Dre/rox,	 were	






in	 vitro	 application,	 three	 recombinases,	 Cre,	 Dre	 and	 VCre,	 were	 explored	 to	
integrate	 promoters	 into	 a	 pathway	 of	 interest	 for	 gene	 expression	 level	
diversification	in	metabolic	engineering.		
To	attempt	broader	application	of	the	recombinases	for	metabolic	engineering,	a	side	
project	 in	metabolic	 engineering	was	 also	 involved	 in	my	PhD	 study.	As	 part	 of	 a	
collaborative	Synthetic	Natural	Product	(SynNP)	project	applying	synthetic	biology	to	














Site-specific	 recombinases	 are	 enzymes	 that	 can	 recognize	 short	 specific	 DNA	
sequences	 and	 drive	 recombination	 between	 them	 to	 achieve	 DNA	 excision,	
integration	or	inversion.	An	international	consortium	of	scientists	has	been	working	
on	re-writing	the	genome	of	baker’s	yeast	by	putting	recombination	sites	across	the	
yeast	 genome.	 The	 recombinases	 can	 then	 be	 used	 to	 generate	 random	
modifications	to	accelerate	the	evolution	of	the	species.	I	developed	and	engineered	
a	 set	 of	 recombinases	 to	 further	 engineer	 the	 yeast	 for	 metabolic	 engineering	
applications,	screening	for	evolved	yeast	strains	with	higher	production	of	products	
of	interest.	The	activation	of	the	function	of	the	recombinases	was	designed	to	be	
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Synthetic	 biology	 has	 been	 developing	 rapidly	 in	 recent	 decades	 as	 a	 nascent	
interdisciplinary	engineering	subject	(Figure	1.1).	Based	on	the	principles	of	modern	
cell	and	molecular	biology,	 it	also	 incorporates	and	absorbs	design	principles	from	




in	E.	coli	by	Francois	 Jacob	and	Jacques	Monod	 in	1961	are	taken	as	roots	 for	the	
origin	 of	 synthetic	 biology	 (Cameron,	 Bashor,	 &	 Collins,	 2014).	 However,	
manipulating	 biological	 elements	 is	 not	 as	 easy	 as	 traditional	 well	 developed	




enzymes,	 DNA	 ligase	 and	 the	 invention	 of	 PCR	 during	 the	 1960s	 to	 1980s,	 the	
predecessor	of	synthetic	biology,	genetic	engineering,	became	a	pioneering	subject	
of	 biotechnology.	 Genetic	 engineering	 stood	 out	 from	 traditional	 biology,	 yet	 its	
ability	was	still	 limited	both	because	of	 its	 limitations	on	DNA	cloning	 techniques,	
number	 of	 genes	 that	 can	 be	 modified	 and	 also	 insufficient	 understanding	 of	
biological	 systems.	 One	 of	 the	 most	 important	 techniques	 in	 the	 1990s,	 DNA	
sequencing,	brought	genetic	research	into	the	era	of	“omics”	and	“high-throughput”,	
greatly	 increasing	the	number	of	DNA	engineering	elements	available.	Meanwhile,	
researchers	 focused	 on	 using	 a	 top-down	 method	 to	 study	 genetic	 networks	 by	





Establishment	 of	 synthetic	 biology.	 Deep	 understanding	 of	 the	 properties	 of	
individual	elements,	taking	advantage	of	the	characterized	components	and	building	
a	 new	 system	with	 them	 from	 the	 bottom	 up	 are	 the	 core	 features	 of	 synthetic	
biology.	 Before	 1995,	 Harley	 and	 Lucy	 compared	 the	 difference	 and	 similarity	
between	genetic	networks	and	electronic	circuits	and	analyzed	how	signal	timing	and	






and	 his	 colleagues,	 was	 published	 (Gardner,	 Cantor,	 &	 Collins,	 2000).	 It	 achieved	




the	 repressilator	 was	 designed	 with	 a	 third	 system	 added	 to	 the	 two	 promoter-
repressor	 pairs,	 resulting	 in	 periodic	 oscillation	 of	 output	 fluorescence	 (Elowitz	&	










Though	 simple,	 the	 design	 of	 the	 toggle	 switch	 and	 repressilator	 illustrated	 the	
	 -	3	-	
universal	“part-circuit-device”	structure	of	a	synthetic	biological	system.	Parts	are	the	
basic	 genetic	 components,	 such	 as	 inducible	 promoters	 and	 their	 corresponding	
repressor	 proteins;	 then	 the	 combination	 of	 a	 certain	 promotor	 and	 repressor	
protein	form	a	circuit	or	module,	which	is	further	combined	with	others	to	constitute	
the	final	device	that	is	expected	to	show	a	certain	behavior	or	fulfill	a	desired	function.	











of	 parts	 to	 target	 host	 organisms,	 the	 noises	 and	 side	 effects	 can	 be	 reduced	 or	






The	 traditional	 way	 to	 assemble	 biological	 parts	 is	 to	 use	 different	 restriction	
enzymes	to	cut	and	ligate	the	basic	elements.	Since	different	groups	have	different	










a	 competition	 between	 several	 universities,	 which	 later	 became	 the	 first	 iGEM	
(international	 Genetically	 Engineered	 Machine	 competition)	 to	 design	 functional	
genetic	devices	using	 the	 standardized	parts.	 The	 format	of	 the	 competition	each	
year	is	a	great	way	to	teach	the	concepts	of	synthetic	biology,	to	inspire	innovation	
and	stimulate	creativity	among	undergraduate	students.	Teams	participating	in	the	
competition	 share	 and	 contribute	 to	 the	 library	 of	 interchangeable	 standardized	
parts,	 which	 became	 the	 Registry	 of	 Standard	 Biological	 Parts	















Branching	 of	 synthetic	 biology.	 Since	 synthetic	 biology	 is	 a	 young	 engineering	
discipline	with	a	broad	choice	of	circuits	to	design	and	problems	to	solve,	many	sub-
directions	and	fields	of	application	have	emerged	with	 its	expansion.	 In	general,	 it	






(Farzadfard	&	 Lu,	 2014),	 bio-computers	 (Baumgardner	 et	 al.,	 2009;	Haynes	 et	 al.,	
2008),	 	 RNA	 synthetic	 biology	 like	 riboswitches	 (Bayer	&	 Smolke,	 2005;	 Chappell,	
Watters,	Takahashi,	&	Lucks,	2015;	Isaacs,	Dwyer,	&	Collins,	2006;	Mandal	&	Breaker,	









Beside	 the	 tools	 above,	 one	 of	 the	 hottest	 topics	 in	 synthetic	 biology	 is	 the	
engineering	 of	 genome	 editing	 tools	 like	 ZFNs,	 TALEN	 and	 CRISPR/Cas9	 (Gaj,	
Gersbach,	 &	 Barbas,	 2013;	 Hsu,	 Lander,	 &	 Zhang,	 2014;	Wood	 et	 al.,	 2011).	 The	








biofuel	 production	 (Atsumi,	 Hanai,	 &	 Liao,	 2008;	 d'Espaux,	 Mendez-Perez,	 Li,	 &	
Keasling,	2015),	to	produce	bio-materials	(Chessher	et	al.,	2015;	R.	Langer	&	Tirrell,	
2004;	 Wagner,	 Sprenger,	 Rebmann,	 &	Weber,	 2016),	 pharmaceuticals	 and	 other	
high-value	chemicals	(Chang	&	Keasling,	2006;	Galanie,	Thodey,	Trenchard,	Filsinger	
Interrante,	 &	 Smolke,	 2015;	 Keasling,	 2012;	 Paddon	 &	 Keasling,	 2014a;	 Thodey,	
Galanie,	&	Smolke,	2014).	There	are	also	various	other	applications	ranging	from	bio-
printing	 (Levskaya	 et	 al.,	 2005),	 biosensors	 for	 pollution	 detection	 or	 disease	
















al.,	 2009;	 Krivoruchko,	 Siewers,	 &	 Nielsen,	 2011;	 Siddiqui,	 Thodey,	 Trenchard,	 &	
Smolke,	2012),	plants	 (Baltes	&	Voytas,	2015;	Liu,	Yuan,	&	Stewart,	2013;	Sarrion-
Perdigones	et	 al.,	 2013)	 and	 recently	mammalian	 cells	 (Auslander	&	Fussenegger,	
2013;	Kis,	Pereira,	Homma,	Pedrigi,	&	Krams,	2015;	Lienert,	Lohmueller,	Garg,	&	Silver,	
2014),	 and	 lower	 to	 minimal	 cell	 and	 cell-free	 systems	 (Forster	 &	 Church,	 2007;	
Hodgman	&	Jewett,	2012;	Jewett,	Calhoun,	Voloshin,	Wuu,	&	Swartz,	2008;	Kuruma,	
Stano,	 Ueda,	 &	 Luisi,	 2009).	 Since	 our	 knowledge	 about	 the	 even	 the	 simplest	





Scale-up,	automation	and	 industrialization.	With	all	 the	advances	 in	 fundamental	
and	 application	 related	 research,	 synthetic	 biology	 is	 also	 entering	 the	 stage	 of	
commercial	 transformation.	 Typically,	 a	 synthetic	 biology	 project	 includes	 the	
process	of	design,	construction	and	function	characterization.	The	process	of	circuit	
design	 is	 the	 section	 that	 requires	 the	 most	 human	 intelligence.	 Accurate	
construction	of	the	circuits	is	also	important	but	with	a	well-established	protocol	for	
DNA	assembly,	it	is	less	difficult.	However,	unlike	writing	a	computer	language,	the	
construction	 section	 is	 more	 time	 and	 manpower	 consuming,	 especially	 as	 the	








is	 true	 for	 synthetic	 biology.	 Besides	 the	 diverse	 databases,	which	 perform	 static	
storage	 of	 different	 DNA,	 RNA	 and	 protein	 sequences,	 more	 interactive	 tools	 to	


















are	 too	 diverse	 and	 not	 easy	 to	 standardize.	 Future	 work	 on	 simplifying	 and	






In	 order	 to	 manipulate	 genetic	 elements	 and	 design	 a	 system	 with	 predictable	
behavior,	 the	 function	 and	 inherent	 characteristics	 have	 to	 be	 known	 for	 each	
	 -	9	-	
element.	On	 top	of	 the	 knowledge	of	natural	 genetic	parts,	 there	are	 some	basic	
principles	to	follow	for	circuit	design	to	fit	the	parts	into	target	devices	or	systems.		
Design	 strategies.	Synthetic	 biology	 is	 an	 engineering	 discipline,	 and	 some	of	 the	
design	principles	can	be	passed	on	 from	traditional	engineering	subjects.	 In	2005,	












design,	 fabricate	 and	 characterize.	 Abstraction	 refers	 to	 extracting	 the	 key	
information	of	each	level	of	the	design	(part,	device	and	system)	from	the	complex	
biological	 context	 and	 simplifying	 the	 system	 to	 a	 level	 such	 that	 a	mathematical	
model	 can	 be	 used	 to	 evaluate	 the	 dynamic	 behavior.	 Therefore,	 the	 synthetic	
biological	 engineer	 should	 be	 able	 to	 use	 standardized	 language	 to	 design	 the	
systems	modularly	like	a	programmer	and	think	through	the	method	to	characterize	
and	 quantify	 the	 function	 even	 at	 the	 design	 stage.	 Beside	 the	 three	 classical	
strategies,	 the	 inherent	 characteristics	 of	 diverse	 parts	 and	 systems	 should	 be	
considered	 to	 flexibly	 adjust	 the	 design	 and	 optimize	 the	 target	 functions	
(Andrianantoandro,	Basu,	Karig,	&	Weiss,	2006).			
Characterization	 and	 quantification.	 Synthetic	 biology	 has	 spanned	 diverse	 fields	
and	 served	 many	 different	 goals.	 For	 different	 applications,	 there	 are	 various	
methods	for	part	characterization.		Though	diverse,	there	are	common	basic	rules	or	




In	 the	 early	 years	 of	 synthetic	 biology,	 two	 quantification	 characteristics,	 PoPS	
(Polymerase	 Per	 Second)	 and	 RIPS	 (Ribosomes	 Per	 Second)	 were	 proposed	 to	
describe	 the	 rate	 of	 TX-TL.	 	 For	 real	 experimental	 measurement,	 reporters	 are	
needed	 to	 evaluate	 the	 parameters	 of	 a	 device	 or	 system.	 Fluorescent	 tags	 or	
luciferase	are	the	most	commonly	used	reporters	for	the	quantification	of	protein	






for	metabolic	 pathways.	 Some	 progress	 has	 been	 achieved	 by	 the	 invention	 and	
application	of	flow	cytometry	and	microfluidics	for	single	cell	level	characterization,	
and	 characterization	 by	 cell-free	 systems	 for	 catalytic	 proteins	 in	 metabolic	
engineering	(Dudley,	Karim,	&	Jewett,	2015).		
Performance	 assessment.	 When	 characterization	 of	 the	 elementary	 parts	 and	
individual	modules	is	completed,	the	system	as	a	whole	should	be	further	evaluated	
on	 its	 stability,	 burden	on	host,	 robustness,	 noise	 and	 sensitivity/response	 speed.	
























be	 categorized	 to	 three	 families:	 endonuclease-mediated	 assembly,	 long-overlap-
based	 assembly	 and	 site-specific	 recombination-based	 assembly	 (Casini,	 Storch,	
Baldwin,	&	Ellis,	2015).		On	top	of	the	normal	cut	and	ligation	by	normal	restriction	
endonucleases	(RE)	and	ligases,	some	REs	with	the	same	digestion	overhangs	were	
chosen	 to	 standardize	bioparts	 for	 idempotent	assembly	of	 two	 fragments	with	a	
vector,	like	BioBrick	and	BglBrick	(Anderson	et	al.,	2010;	Shetty	et	al.,	2008).	These	
methods	were	good	 inventions	 in	 the	early	days	but	 their	 assembly	ability	 is	 also	
limited,	with	limited	number	of	parts	that	can	be	assembled	and	remaining	scars	after	
ligation.	Later,	a	group	of	assembly	methods	based	on	the	special	family	of	restriction	
endonuclease,	 the	 type	 IIs	RE,	were	developed	and	widely	used,	 including	Golden	
Gate,	 Moclo,	 and	 GoldenBraid	 (Engler,	 Gruetzner,	 Kandzia,	 &	 Marillonnet,	 2009;	
Sarrion-Perdigones	et	al.,	2013;	E.	Weber,	Engler,	Gruetzner,	Werner,	&	Marillonnet,	
2011).	 Since	 the	overhangs	of	 the	 cutting	 site	 can	be	artificially	designed	and	 the	
recognition	 sites	 have	 directionality,	 there	 are	 many	 advantages	 of	 this	 type	 of	










restriction	 sites,	 and	 can	 assemble	multiple	 large	 fragments	 (Gibson	et	 al.,	 2009).	
Besides	 in	 vitro	 DNA	 repair,	 the	 assembly	 can	 also	 be	 achieved	 in	 vivo	 through	
homologous	recombination	by	natural	DNA	repair	machinery	in	live	microbes	like	E.	
coli,	Bacillus	subtilis	and	Saccharomyces	cerevisiae.	The	invention	of	circular	polymer-







the	 site-specific	 integrases	 (Colloms	 et	 al.,	 2014a;	 L.	 Zhang,	 Zhao,	 &	 Ding,	 2011).		









and	 in	 vivo	 recombination	 assembly	 are	 good	 options.	 Sometimes	 one	 method	
cannot	 meet	 the	 need	 to	 fully	 assemble	 a	 circuit,	 and	 multi-round	 hierarchical	
construction	can	be	used	to	accelerate	the	speed	and	at	the	same	time	ensure	the	
	 -	13	-	
quality	 of	 construction.	 There	 are	 many	 examples	 of	 hierarchical	 construction:	
YeastFab	assembly	is	a	specific	Golden	Gate	assembly	method	that	alternatively	uses	
BsaI	 and	 BsmBI	 for	 pathway	 construction	 (Y.	 Guo	 et	 al.,	 2015);	 DNA	 Assembler	
combines	 in	 vitro	 overlap	 extension	 and	 in	 vivo	 yeast	 recombination	 for	 large	
pathway	 construction	 (Shao,	 Zhao,	 &	 Zhao,	 2009).	 In	 the	 international	 project	 to	
synthesize	 the	 genome	 of	 S.cerevisiae,	 multiple	 methods	 were	 used	 at	 different	
scales	for	the	construction,	including	overlap-extension	PCR,	Gibson	assembly,	yeast	
in	vivo	assembly	and	auxotrophic	marker	swapping	(Dymond	et	al.,	2011;	Jovicevic,	
Blount,	 &	 Ellis,	 2014).	 Other	 methods	 like	 MODAL	 and	 PaperClip,	 which	 use	
standardized	linkers	or	adaptors,	are	also	good	complementary	methods	that	can	be	











synthesized	 genome,	 most	 genetic	 information	 was	 maintained	 and	 only	 some	
watermark	 sequences	 were	 introduced	 together	 with	 several	 designed	 gene	
deletions.	 Though	 not	 many	 changes	 were	 made,	 this	 proved	 that	 an	 artificially	
synthesized	genome	can	be	maintained	 stably	 in	 a	natural	organism	and	 function	
similarly	 to	 the	natural	one,	which	 is	an	 important	milestone	 in	 synthetic	biology,	
proving	technical	feasibility	of	genome	synthesis.	However,	merely	copying	nature’s	
design	is	not	the	goal	of	synthetic	biology.	The	next	step	is	to	rationally	add	functional	




genome	based	on	 the	 JCV-syn1.0	 strain	 and	 recently	 they	published	 their	 newest	




not	only	extends	genome	synthesis	 to	eukaryotes	but	also	 includes	more	 rational	
changes	to	facilitate	further	genome	engineering	(Dymond	et	al.,	2011).	Now,	people	







most	 intensively	 studied.	 S.	 cerevisiae	 was	 the	 first	 eukaryotic	 genome	 that	 was	
sequenced,	 and	 this	 was	 followed	with	 numerous	 studies	 on	 gene	 functions	 and	
interaction	for	the	genome	annotation	(Costanzo	et	al.,	2010;	Goffeau	et	al.,	1996).	
The	 annotation	 and	 updates	 are	 stored	 in	 the	 Saccharomyces	 Genome	 Database	
(SGD).	As	 to	 the	genome	size,	 the	 total	 length	 is	more	 than	12	Mbp,	 including	16	






of	 synVI,	 termed	 semi-synVIL	 (Dymond	 et	 al.,	 2011).	 Rather	 than	 simply	 copying	
















conditions,	which	 can	 be	 further	 recovered	 by	 the	 SCRaMbLE	 system(Shen	 et	 al.,	
2017).	Other	traits	of	the	synthetic	strains	were	evaluated	and	compared	with	the	
wild	 type	 strain	 by	 analysis	 of	 chromosome	 3D	 structures,	 transcriptomics	 and	
proteomics	profiles,	cell	cycle,	rDNA	loci	effect,	etc.	The	second	design	of	removing	
all	 tRNA	 genes	 from	 synthetic	 chromosomes	 generated	 some	 problems	 to	 the	
synthesis	 of	 some	 chromosomes,	 but	 this	was	 solved	 by	 supplementing	 essential	
tRNA	genes	 separately.	At	 the	 same	 time	a	Neochromosome	composed	of	all	 the	


























sufficient	 to	 describe	 a	 biological	 function	 systematically.	 Also,	 the	 accuracy	 of	
	 -	17	-	
genome	sequence	recognition	and	cutting	is	still	not	stringent	enough	to	avoid	all	off-
target	 effects,	 which	 makes	 it	 even	 harder	 to	 correctly	 modify	 multiple	 genes	
simultaneously	and	efficiently.	Another	type	of	genome	editing	tool	does	not	target	
specific	genes	but	is	used	to	generate	sequence	diversity	randomly	across	the	whole	
genome	 with	 cell	 replication,	 and	 this	 is	 called	 multiplex	 automated	 genome	
engineering	(MAGE)	(H.	H.	Wang	et	al.,	2009).	It	accelerates	the	process	of	creating	
variations	 in	 new	 generations	 and	 with	 proper	 selection	 methods,	 strains	 with	
favorable	 traits	under	selection	can	be	screened	out,	which	 is	also	called	directed	
evolution.	 By	 MAGE,	 the	 deoxy-D-xylulose-5-phosphate	 (DXP)	 biosynthesis	
pathway	was	optimized	in	E.	coli	and	this	successfully	improved	lycopene	production	
within	several	days	(H.	H.	Wang	et	al.,	2009).	However,	each	time	MAGE	is	applied	
for	 a	 different	 purpose,	 the	 ss-oligonucleotides	 need	 to	 be	 re-designed	 and	 re-
synthesized.	Furthermore,	the	variations	were	generated	only	in	certain	genes	in	the	




hundreds	 of	 such	 sites	 distributed	 across	 the	 whole	 genome,	 it	 can	 generate	
theoretically	 infinite	 recombination	 possibilities	 of	 random	 variations	 needed	 for	
directed	evolution.		Compared	with	ZFNs,	TALENs	and	CRISPR,	the	SCRaMbLE	system	
can	target	multiple	genes	at	the	same	time	with	precision;	compared	with	MAGE,	it	
can	 generate	 random	 variations	 across	 the	 whole	 genome	 to	 achieve	 chassis	
optimization.	 Though	 it	 needs	 whole	 genome	 synthesis	 to	 introduce	 the	






















































the	 sites	 to	 achieve	 either	 excision,	 integration	 or	 inversion	 of	 DNA	 fragment	






genome	 into	 the	 host	 genome.	 The	 basic	 process	 for	 site-specific	 recombination	
includes	sequence	recognition,	protein-DNA	binding	and	catalysis,	and	DNA	strand	
exchange.	 Based	 on	 the	 conserved	 nucleophilic	 amino	 acid	 residue	 they	 use	 for	







Structure	 of	 recombination	 site.	Normally,	 a	 recombination	 site	 consists	 of	 two	
palindromic	arms	and	one	spacer	region	between	the	two	arms.	The	palindromic	arm	
is	 responsible	 for	binding	 the	 recombinase	and	 the	 spacer	 region	 is	 for	homology	
recognition	and	strand	exchange.		
Process	 of	 recombination.	 At	 the	 start	 of	 the	 recombination,	 four	 recombinase	
subunits	are	recruited	to	the	two	recombination	sites	and	approach	each	other	to	be	
close	 in	 space;	 after	 recombinase-site	 binding,	 recombinase	 becomes	 covalently	








of	 a	 recombination	 site.	When	 two	 recombination	 sites	 are	 located	 on	 one	 DNA	
fragment	linearly,	if	they	are	in	the	same	orientation,	recombination	will	result	in	the	
excision	 of	 the	 fragment	 between	 them;	 if	 they	 are	 in	 the	 opposite	 orientation,	
recombination	will	result	in	inversion	of	the	intervening	fragment	(Figure	1.3b).	One	









Flp	 and	 Cre	 are	 the	 earliest	 discovered	 and	most	 studied	 DNA	 tools	 for	 genome	
editing	(Sauer,	1987).	Though	found	in	yeast	and	bacteriophage	respectively,	these	
recombinases	have	been	expressed	and	used	in	other	species,	including	mammalian	
cells,	 for	 genome	 tailoring	 (Nagy,	 2000;	 Nern,	 Pfeiffer,	 Svoboda,	 &	 Rubin,	 2011;	
Schwenk,	Kuhn,	Angrand,	Rajewsky,	&	Stewart,	1998).		Beside	single	genes,	they	have	





2014).	The	crystal	 structures	of	Cre	and	Flp	as	well	 the	structures	of	 the	SSR-DNA	




biochemical	 characterization	was	 also	 reported	 (Ghosh	 &	 Van	 Duyne,	 2002).	 The	
	 -	21	-	
purification	 method	 was	 further	 developed	 and	 a	 commercial	 product	 is	 even	
available	 for	academic	use	 (Cantor	&	Chong,	2001).	The	 in	vitro	 function	was	also	
used	for	studying	structure	and	function	of	the	recombination	sites	and	for	screening	




people	 started	 to	 explore	 and	 extend	 the	 potential	 of	 the	 original	 systems	 by	
engineering	the	recombinase	and	recombination	sites.		
For	 the	 SSR	 engineering,	 directed	 evolution	methods	were	used	 to	 generate	 new	
recombinase	 variants	 for	 binding	 new	 sites	 (Buchholz	 &	 Stewart,	 2001).	 Another	
reason	for	the	engineering	of	the	recombinase	is	that	sometimes	the	heterologous	
expression	of	 the	 recombinase	 results	 in	 toxicity	 to	 the	host	 strain,	 in	most	 cases	
because	 of	 the	 existence	 of	 pseudo-sites	 on	 host	 genome	 (Janbandhu,	 Moik,	 &	
Fassler,	2014;	Loonstra	et	al.,	2001).	To	reduce	off-target	effects,	recombinase	Cre	
has	 been	 engineered	 to	 improve	 recombination	 accuracy	 by	 destabilizing	 binding	
cooperativity	(Eroshenko	&	Church,	2013).		
While	 SSR	 engineering	 provides	 some	new	 recombinase	 versions,	 there	 are	more	
studies	focusing	on	the	engineering	of	recombination	sites.	Since	the	structure	of	a	
recombination	 site	 is	 categorized	 as	 spacer	 region	 and	palindromic	 arms,	 the	 site	
mutants	were	 generated	 and	 studied	 separately	 for	 the	 two	 regions	 for	 different	
purposes	(Kimi	Araki	&	Yamamura,	2012).	Taking	the	Cre/loxP	system	as	an	example,	
the	34bp	loxP	site	is	composed	of	a	13-8-13	arm-spacer-arm	structure	(Figure	1.4a).	




Figure	 1.4|	 Structure	 of	 recombination	 site,	 site	 engineering	 and	 application.	 a.	
Structure	of	loxP	wild	type	site.	b.	Structure	of	engineered	symmetrical	loxPsym	site.	
c.	 Diagrammatic	 sketch	 of	 recombinase-mediated	 cassette	 exchange	 (RMCE).	 d.	
Illustration	of	LE-RE	double	mutant	strategy.		
	
Design	 of	 RMCE	 strategy.	 In	 a	 fundamental	 study	 on	 the	 function	 of	 the	 spacer	
region,	mutant	 loxP	 sites	with	 single	 base	 substitution	mutation	were	 created	 to	





(Figure	 1.4b).	 The	 completely	 symmetrical	 spacer	 enabled	 that	 DNA	 excision	 and	
inversion	can	happen	in	equal	chance	between	loxPsym	sites.	Twenty	years	later,	this	
loxPsym	 site	was	 chosen	 as	 a	 basic	 element	 for	 the	design	of	 the	 yeast	 synthetic	
chromosomes	to	enable	the	SCRaMbLE	process	in	the	synthetic	genome.	Many	other	











in	 both	 directions.	 However,	 the	 possibility	 of	 molecular	 collision	 of	 two	
recombination	 sites	 for	 excision	 and	 integration	 are	 different:	 the	 possibility	 of	
recombination	of	two	sites	that	are	not	associated	in	the	cell	for	integration	is	lower	
than	that	of	two	sites	which	are	located	on	the	same	piece	of	DNA	for	excision.	To	
solve	the	problem	of	 lower	 integration	efficiency,	 the	arm	regions	of	 the	 loxP	site	






A	 “LE+RE”	hybrid	 site	 and	wild	 type	 loxP	 site	 can	be	generated	by	 the	process	of	
integration	between	LE	and	RE	 site	 (Figure	1.4d).	 Since	 the	binding	affinity	of	 the	
hybrid	site	is	reduced,	the	reverse	recombination	between	the	wild-type	and	hybrid	
site	 becomes	 more	 difficult,	 which	 interrupts	 the	 reversibility	 and	 promotes	 the	





The	 recombination	 process	 can	 be	 turned	 on	 by	 certain	 inputs	 and	 tuned	 by	 the	
expression	level	of	the	recombinase.		
	 -	24	-	
Transcriptional	 regulation.	 Taking	 S.	 cerevisiae	 as	 an	 example,	 the	 expression	 of	




for	 gene	 knock-out.	 However,	 sometimes	 expression	 driven	 by	 strong	 inducible	
promoters	like	PGAL1	has	a	leaky	effect	(Gohil,	Thompson,	&	Greenberg,	2005),	making	
it	less	tightly	controlled	and	undesirable	for	computing	applications.	To	lowering	the	




translational	 regulatory	 strategy	 can	 also	 be	 applied	 to	 achieve	 tighter	 control	 of	
recombinase	function.	In	natural	cell	systems,	there	are	a	class	of	nuclear	receptors	
that	can	sense	hormones	and	certain	other	molecules	to	regulate	the	expression	of	








best	 studied	and	have	been	applied	 to	 recombinase	 regulation.	 In	 the	absence	of	
ligand,	the	nuclear	receptor	is	bound	by	heat	shock	proteins	(HSPs)	 in	the	cytosol;	
with	the	binding	of	a	certain	kind	of	ligand,	the	nuclear	receptor	is	released	from	the	
HSPs	 and	 translocated	 from	 the	 cytoplasm	 to	 the	 nucleus	 for	 transcription	
function(Linja	 et	 al.,	 2004).	 Since	 the	 recombinase	 is	 a	 DNA	 binding	 protein,	 it	 is	
feasible	 to	 simulate	 the	natural	design	and	 fuse	 the	 recombinase	with	 the	LBD	 to	
achieve	spatial	control.	This	idea	was	first	successfully	achieved	with	FLP	fused	with	
	 -	25	-	
estrogen-binding	domain	 (EBD)	 in	 a	mammalian	 cell	 line	 (Logie	&	 Stewart,	 1995).	
Later,	 more	 successful	 pairs	 of	 fusion	 proteins	 were	 reported,	 including	 Cre	 and	
progesterone-binding	domain	(PBD)	or	Dre	and	PBD	regulated	by	synthetic	steroid	
RU486	 in	 mammalian	 cells	 (Anastassiadis	 et	 al.,	 2009;	 Kellendonk	 et	 al.,	 1996;	
Wunderlich,	Wildner,	Rajewsky,	&	Edenhofer,	2001).	The	fusion	protein	strategy	not	
only	works	in	mammalian	cells	where	the	natural	system	exists,	but	also	works	well	
in	 yeast	 with	 one	 example	 being	 the	 fusion	 of	 Cre-EBD	 applied	 to	 a	mother	 cell	
enrichment	program	in	S.	cerevisiae	(Lindstrom	&	Gottschling,	2009).	In	addition	to	
fusing	 with	 recombinase,	 the	 LBDs	 have	 also	 been	 engineered	 for	 the	 design	 of	
artificial	 transcription	 factors	 (ATFs)	 to	 tune	 gene	 expression	 like	 that	 of	 the	








Though	 tyrosine	 recombinases	 are	 the	main	 focus	 of	my	 PhD	 project,	 the	 serine	






attachment	 process	 of	 a	 phage	 site	 to	 a	 bacterial	 host	 site:	 attP	 and	 attB.	 The	
integration	 of	 attP	 to	 attB	 will	 generate	 two	 new	 sites	 called	 attL	 and	 attR.	 The	
integration	 reaction	 of	 this	 type	 of	 recombination	 is	 irreversible	 unless	 a	
recombination	directionality	 factor	 (RDF)	 is	 introduced	(Smith,	Brown,	McEwan,	&	
Rowley,	2010)	(Figure	1.5a).	Only	with	the	presence	of	an	RDF	can	fragment	excision	
	 -	26	-	
happen	 between	 the	 attL	 and	 attR	 sites,	which	 makes	 it	 ideal	 for	 unidirectional	




the	 structure	 and	 function	 of	 the	 recombination	 site	 by	 testing	 recombination	
efficiency	of	target	site	mutants	(McEwan,	Rowley,	&	Smith,	2009;	Singh,	Ghosh,	&	
Hatfull,	2013).	An	in	vitro	mechanistic	model	was	also	developed	to	describe	the	in	












logic	 gates	 can	 be	 more	 tightly	 controlled	 compared	 with	 traditional	 inducible	







matched	 to	 enable	 recombination	 (Figure	 1.5b).	 Due	 to	 time	 limitation	 and	 the	
compatibility	with	 the	 design	 of	 Sc	 2.0	 synthetic	 chromosome,	 the	 application	 of	
	 -	27	-	
serine	 recombinases	 was	 not	 included	 in	 this	 project.	 However,	 the	 serine	
recombinases	could	be	a	good	substitute	for	in	vitro	use	of	the	tyrosine	recombinases	
and	a	 good	 substitute	 for	 in	 vivo	 use	 to	design	Neochromosomes	with	 the	 serine	
recombinase	recognition	sites	in	future.			
	






Another	 fast	 growing	 aspect	 of	 synthetic	 biology	 is	 its	 coupling	 with	 metabolic	
engineering	 for	use	 in	 industrial	 biotechnology	 to	produce	biofuels,	medicine	and	







very	 low	 levels,	making	 them	difficult	 to	detect.	Even	 though	many	chemicals	are	
screened	out	from	nature,	the	species	producing	them	is	sometimes	not	cultivable	
under	 laboratory	 conditions,	 let	 alone	 in	 industrial	 fermentation.	 In	 traditional	
	 -	28	-	
metabolic	engineering,	metabolic	analysis,	substrate	optimization	and	direct	genetic	
modification	 were	 the	 most	 common	 methods	 for	 improving	 the	 yield	 of	 target	





more	 precisely	 and	 systematically.	With	 the	 continuously	 decreasing	 cost	 of	 DNA	
synthesis	 and	 invention	of	 diverse	 assembly	methods,	 it	 is	 feasible	 and	becoming	
easier	 to	 design	 and	 construct	 pathways	 and	 transfer	 them	 to	 specific	 hosts	 for	
heterologous	expression	(DeLoache	et	al.,	2015;	Hawkins	&	Smolke,	2008;	Kosuri	&	
Church,	 2014;	 Paddon	 &	 Keasling,	 2014b;	 Thodey	 et	 al.,	 2014).	 The	 engineering	
process	of	a	metabolic	pathway	was	recently	reviewed	in	2016,	 including	pathway	
design,	construction	and	screening	(Smanski	et	al.,	2016).	The	first	and	core	part	in	
pathway	 design	 is	 to	 determine	 what	 genes	 are	 to	 be	 used	 for	 natural	 product	
synthesis.	With	the	increasing	volume	of	genome	sequencing	data,	researchers	found	
that	 genes	 encoding	 the	 synthesis	 of	 a	 natural	 product	 are	 usually	 colocalized	 in	
compact	biosynthetic	gene	clusters	(BGCs).	Through	genome	mining	and	homology	









Through	 the	 first	 step	 of	 genome	 mining,	 targeted	 BGCs	 for	 pathways	 can	 be	
refactored	for	heterologous	expression.	For	successful	heterologous	expression,	it	is	
necessary	 to	 fine-tune	the	expression	and	 function	of	each	gene	 in	a	new	cellular	
	 -	29	-	
system.	It	is	not	the	case	that	every	gene	should	be	expressed	as	strongly	as	possible	
to	maximize	production.	 From	 the	perspective	of	 transcriptional	 regulation,	many	
regulatory	devices	have	been	discovered	and	engineered	 in	bacteria	 and	yeast	 to	
obtain	enough	regulatory	parts	with	a	wide	range	of	transcription	initiation	strengths	






sometimes	 there	 are	 too	 many	 genes	 in	 a	 pathway	 and	 the	 number	 of	 possible	
combinations	 is	 too	 high	 to	 cover.	 On	 one	 hand,	 a	 process	 called	 multivariate	





chemicals	 or	 intermediates	 by	 triggering	 of	 an	 efflux	 pump	 (Tahlan	 et	 al.,	 2007),	
chemically	 inducible/repressible	 promoters	 or	 RNA	 aptamer	 sensors	 (Michener,	
Thodey,	Liang,	&	Smolke,	2012;	Siddiqui	et	al.,	2012).	With	the	help	of	fluorescent	
reporters,	cell	sorting	can	be	used	to	select	the	clones	with	higher	production	from	
the	 library	 more	 efficiently.	 Besides	 engineering	 of	 gene	 regulation,	 protein	





















scale	 engineering	 method	 including	 MAGE	 (H.	 H.	 Wang	 et	 al.,	 2009)	 (multiplex	
automated	 genome	 engineering)	 and	 TRMR	 (Warner,	 Reeder,	 Karimpour-Fard,	
Woodruff,	&	Gill,	 2010)	 (trackable	multiplex	 recombineering)	were	used	 to	 either	
improve	the	production	of	lycopene	quickly	or	generate	faster	growing	strains	under	
industrially	related	conditions	in	E.	coli.		
In	 addition	 to	 the	 above	 methods,	 other	 directions	 like	 engineered	 symbiotic	




Among	 the	 huge	 amount	 of	 natural	 product	 producing	 pathways,	 the	 pigment	
generating	pathways	are	good	benchmark	pathways	for	different	research	purposes	
with	their	advantage	of	visibility.	In	this	research,	two	pigment	generating	pathways,	
the	 b-carotene	 and	 violacein	 pathways	 were	 used	 for	 demonstrating	 pathway	
diversification	 in	 different	 chapters.	 b-carotene	 is	 a	 red-orange	 pigment	 that	 is	





difficult	 extraction	 from	 plants,	 microbial	 production	 and	 fermentation	 has	 been	
investigated	 and	 attempted.	 It	 has	 been	 reported	 that	 carotenoids	 can	 be	
synthesized	in	yeast	strains	and	various	productions	were	observed	in	these	different	
strains	(Mata-Gomez,	Montanez,	Mendez-Zavala,	&	Aguilar,	2014).		In	yeast	strains	
like	 S.	 cerevisiae	 and	 X.	 dendrorhous,	 the	 precursor	 of	 carotenoids,	 farnesyl	
diphosphate	(FPP),	can	be	synthesized	from	acetyl	CoA	by	local	yeast	enzymes;	then	
three	 heterogenous	 genes,	 CrtE,	 CrtYB	 and	 CrtI,	 were	 introduced	 for	 following	
conversions	 towards	 b-carotene	 (Verwaal	 et	 al.,	 2007).	 FPP	 is	 converted	 to	




finally,	 enzyme	 CrtYB	 plays	 the	 other	 role	 as	 cyclase	 to	 convert	 lycopene	 to	 the	
orange	 color	 b-carotene	 (Figure	 1.6a).	 Besides	 b-carotene	 pathway,	 the	 purple	
antibiotic	generating	pathway	–	violacein	pathway	–	also	attracted	commercial	and	
academic	 interests.	Violacein	 is	a	bisindole	pigment	originally	produced	 in	various	
genera	of	bacterial	 strains,	 including	Collimonas,	 Janthinobacterium,	Microbulbifer	
sp.,	 etc	 (Choi,	 Yoon,	 Lee,	&	Mitchell,	 2015).	 The	 key	 genes	 essential	 for	 violacein	
synthesis	have	been	identified	as	VioA,	B,	C,	D,	E	gene	cluster	in	Chromobacterium	
violaceum	by	 DNA	 sequencing,	mutagenesis	 and	 chemical	 analysis	 (August	 et	 al.,	
2000).	 The	 five	 genes	 have	 also	 been	 sub-cloned	 and	 proven	 to	 be	 functional	 to	
synthesize	 violacein	 in	 other	 bacterial	 strains	 like	 E.	 coli	 and	 eukaryotic	





protoxyviolaceinic	 acid	 by	 VioD	 with	 the	 presence	 of	 NADPH,	 H+	 and	 O2;	 the	
protoxyviolaceinic	 acid	 was	 further	 oxidized	 to	 the	 violaceinic	 acid	 by	 VioC	 with	
	 -	32	-	
NADPH,	 H+	 and	 O2;	 after	 the	 above	 five	 enzymatic	 steps,	 the	 violaceinic	 acid	 is	
converted	to	the	purple	violacein	with	a	final	non-enzymatic	step	by	auto-oxydization	
(Lee	et	al.,	2013)	(Figure	1.6b).	Besides	the	main	flux	towards	violacein,	some	side	













One	major	application	 field	of	natural	products	 is	medical	uses	 for	human	health.	
Antibiotics	 are	 one	 of	 the	 vital	 drug	 discoveries	 benefiting	 human	 lives	 by	 curing	
various	 infections.	 However,	 the	 overuse	 of	 antibiotics	 from	 inappropriate	
	 -	33	-	
prescribing	 and	 extensive	 agricultural	 use	 has	 resulted	 in	 the	 crisis	 of	 antibiotic	
resistance	(Ventola,	2015).	At	the	same	time,	the	number	of	new	drugs	available	is	
dropping	constantly	in	recent	years,	making	the	situation	even	worse.	Much	research	
effort	 has	 been	 applied	 to	 studying	 the	 mechanisms	 of	 antibiotic	 resistance	 and	
developing	new	medicines.	Antibiotic	resistance	is	normally	due	to	genetic	mutations	
that	can	lead	to	quite	diverse	mechanisms	to	escape	the	function	of	antibiotics.	The	
evolutionary	 rate	 of	 microorganisms	 is	 much	 faster	 than	 the	 speed	 of	 new	 drug	
discovery.	 Screening	 from	 natural	 resources	 and	 chemical	 synthesis	 are	 the	main	
methods	for	new	drug	discovery.	However,	the	screening	process	is	restricted	by	low	
level	 production	 and	 fermentation	 problems	 as	 mentioned	 above,	 and	 chemical	
synthesis	is	of	high	cost	and	hard	to	achieve	sometimes	because	of	the	lack	of	proper	
catalysts.	 Synthetic	 biology	 provides	 an	 engineering	 platform	 that	 can	 generate	 a	
huge	amount	of	genetic	diversity	which	can	potentially	result	in	chemical	diversity.	
This	 will	 accelerate	 the	 speed	 of	 genetic	 evolution	 of	 natural	 product-producing	












enzyme	genes	 (BSGs)	 from	various	microorganisms	 combinatorically	 to	 synthesize	
and	diversify	natural	product	(NP)-like	compounds	against	TB,	in	collaboration	with	
our	group	and	another	group	in	Canada	to	form	a	three-partner	consortium.	Based	
on	 previous	 research,	 five	 NP	 classes	 were	 chosen	 for	 BSG	 library	 construction,	
	 -	34	-	
including	 non-ribosomal	 peptide	 synthases	 (NRPSs)	 based	 class,	 polyketide	
synthetases	 (PKSs)	 based	 class,	 ribosomally	 synthesized	 and	 post-translationally	
modified	peptides	(RiPPs)	derived	class,	nucleosides	class	and	flavonoids	class.		There	





resistance	 is	due	 to	 the	 failure	of	 the	existing	 compounds	 to	 target	 and	 interrupt	
normal	physiological	processes	of	a	certain	pathogen,	it	is	possible	that	structural	and	
molecular	changes	of	the	antibiotic	compound	can	enable	recapture	of	the	pathogen.	




are	 available	 to	 accommodate	 large	 synthetic	 fragments	 and	 as	 a	 eukaryotic	




et	al.,	2009;	Paddon	&	Keasling,	2014a;	Thodey	et	al.,	2014).	 In	 the	 three-partner	











components	 for	 in	 vitro	 use,	 like	 the	 various	 DNA	 polymerases	 and	 restriction	
enzymes.	Now,	 researchers	 are	 aiming	 to	 put	 together	more	 elements	 in	 vitro	 to	
achieve	more	complex	networks	outside	the	cell.	Combined	with	synthetic	biology,	
gene	circuits	and	networks	can	be	potentially	expressed	and	function	outside	the	cell.	
The	methods	 to	 create	 a	 cell-free	 system	 are	 divided	 into	 crude	 extract	 cell-free	
systems	(CECFs)	and	synthetic	enzymatic	pathways	(SEPs)	(Hodgman	&	Jewett,	2012).	









free	 metabolic	 engineering	 (CFME)	 provides	 an	 alternative	 platform	 for	 natural	
product	synthesis.	In	the	case	of	CFME,	both	purified	enzyme	systems	and	crude	cell	
lysates	 were	 used	 to	 successfully	 activate	 long	 enzyme	 pathways,	 including	 the	
glucose	to	ethanol	conversion	pathway	(Guterl	et	al.,	2012),	non-oxidative	glycolysis	
pathway	 (Bogorad,	 Lin,	&	 Liao,	 2013),	 hydrogen	 generating	 pathways	 (Martin	 del	
Campo	et	al.,	2013),	isoprenoids	biosynthesis	pathways	(X.	Chen	et	al.,	2013;	Harper,	
Bailey,	 Edwards,	Detelich,	&	Keatinge-Clay,	2012;	 Zhu	et	al.,	 2014)	and	high-value	
therapeutic	pathways	(Hagen	et	al.,	2016;	Harper	et	al.,	2012;	Kim,	Kang,	Chae,	Park,	
&	Choi,	2000).	The	advantages	of	CFME	include:	 it	can	be	used	for	debugging	and	




of	design-build-test	 cycling	 (Dudley	et	al.,	2015).	Though	promising,	 there	are	 still	
	 -	36	-	
challenges	in	the	field	like	the	high	cost	of	protein	purification,	stability	and	longevity	








recombination	 systems	 for	metabolic	 pathway	diversification	 and	optimization	on	
both	 pathway	 level	 and	 chassis	 level.	 Two	 pigment	 generating	 pathways,	 the	





In	 chapter	 1,	 all	 the	 related	 background	 is	 introduced	 including	 the	 fundamental	
knowledge	 of	 synthetic	 biology	 including	 basic	 design	 principles	 and	 various	DNA	
assembly	 methods,	 the	 current	 status	 of	 the	 international	 synthetic	 yeast	
chromosome	 project	 Sc	 2.0,	 the	 structure	 and	 function	 of	 recombinases,	 the	
combination	of	synthetic	biology	with	metabolic	engineering,	and	cell-free	synthetic	
biology.	 In	 chapter	 2,	 the	 materials	 and	 methods	 of	 culture	 conditions,	 cloning	
methods	 and	 characterization	 assays	 for	 different	 genetic	 circuits	 are	 described.	
Chapter	3	focuses	on	developing	different	orthogonal	recombinase	devices	in	vivo	for	
serving	 the	 SCRaMbLE	 purpose	 of	 normal	 synthetic	 chromosomes	 and	 a	 tRNA	
Neochromosome.	Based	on	successful	recombinase	function	in	vivo,	a	SCRaMbLE-in	























The	 yeast	 strains	 include	 BY4741	 and	 BY4742	 which	 are	 S288C	 derivatives	 with	
different	mating	types	and	genotypes	(Brachmann	et	al.,	1998).	They	were	used	for	
function	testing	assays	for	various	DNA	constructs.	The	synthetic	strains	were	used	







































MATa	 leu2∆0	 met15∆0	 LYS2	 ura3∆0	
his3∆1	SYNII	
SynIII	 S.	cerevisiae	
MATa	 leu2∆0	 met15∆0	 LYS2	 ura3∆0	
his3∆1	SYNIII	
SynII	SynXII	 S.	cerevisiae	
MATa	 his3Δ1	 leu2Δ0	 ura3Δ0	 MET15	 +	
LYS2	synOJ::HIS3	
SynII-III	 S.	cerevisiae	




his3∆1	 synIII	 SYN.SUP61::HO	 synVI	 SYN-
WT.PRE4	IXL-synIXR	
SynV	 S.	cerevisiae	
MATa	 His3Δ1	 leu2Δ0	 met15Δ0	 ura3Δ0	
LYS2	synV	
SynX	 S.	cerevisiae	
MATa	 His3Δ1	 leu2Δ0	 met15Δ0	 ura3Δ0	
SYN10	HO::tR(ccu)J-URA3	
SynV-X	 S.	cerevisiae	








the	 medium	 was	 sterilized	 by	 autoclaving	 and	 stored	 at	 room	 temperature.	 The	
1000X	 ampicillin	 solutions	 and	 1000X	 kanamycin	 solutions	 were	 filter	 sterilized	
through	a	0.22	µm	filter	and	stored	in	1	ml	aliquots	at	-20°C.	The	1000X	antibiotics	




M	 glucose.	 It	 was	 adjusted	 to	 1	 L	 with	 ddH2O	 and	 sterilized	 by	 autoclaving.	 SOB	
medium	was	prepared	with	20	g	Bacto-tryptone,	5	g	Bacto	yeast	extract,	0.58g	NaCl	
and	0.19	g	KCl.	It	was	adjusted	to	1	L	with	ddH2O	and	sterilized	by	autoclave.		





It	 was	 normally	 prepared	 in	 100	ml	 by	mixing	 0.8	 g	 Difco	 Nutrient	 Broth,	 0.40	 g	
NaH2PO4×H2O	 (2.9	 mmol),	 0.65	 g	 Na2HPO4	 (4.6	 mmol)	 and	 ddH2O.	 The	 pH	 was	
adjusted	to	7.0	and	0.7	g	agar	was	added	afterwards	for	autoclaving.	

































All	 DNA	 samples	 and	 DNA	 modifying	 enzymes	 were	 stored	 at	 -20°C	 and	 DNA	
purification	 kits	 were	 stored	 at	 room	 temperature.	 The	 name	 and	 vendor	 of	 the	









































































The	 1X	 running	 buffer	 was	 diluted	 from	 the	 10X	 running	 buffer	 to	 working	
concentration.	5X	SDS-PAGE	loading	buffer	(10	ml)	was	composed	of	250	mM	Tris-
HCl	pH	6.8,	10%	SDS,	30%	glycerol,	5%	β-mercaptoethanol	and	0.02%	bromophenol	




























































The	 reagents	 for	 yeast	 RNA	 extraction	 include	 proteinase	 K	 buffer,	 precipitation	
solution	and	wash	buffer	solution.	The	components	of	the	buffers	are	listed	in	Tables	
2.5,	2.6	and	2.7	respectively.	The	precipitation	solution	was	stored	at	4°C.	For	RNA	





Reagent	 Stock	concentration	 Final	concentration	 Volume	
Potassium	acetate	 7	M	 3	M	 857	µl	
Glacial	acetic	acid	 100%	 11.5%	v/v	 230	µl	
ddH2O	 	 	 913	µl	
Total	 	 	 2000	µl	
Reagent	 Stock	concentration	 Final	concentration	 Volume	
Tris,	pH	8.0	 1	M	(100X)	 10	mM	 20	µl	
EDTA,	pH	8.0	 0.5	M	(100X)	 5	mM	 20	µl	
NaCl	 4	M	 150	mM	 75	µl	
SDS	 10%	w/v	(10X)	 1%	v/v	 200	µl	
Proteinase	K	 20	mg/mL	(50X)	 0.4	mg/mL	 40	µl	
ddH2O	 	 	 1645	µl	
	 -	47	-	
Table	2.7	Wash	Buffer	solution	setup	(4ml)	
Reagent	 Stock	concentration	 Final	concentration	 Volume	
Tris-HCl,	pH	7.5	 1	M	(100X)	 10	mM	 40	µl	
Potassium	acetate	 7	M		(100X)	 60	mM	 34.2	µl	
EtOH	 100%	 60%	v/v	 2400	µl	
ddH2O	 	 	 1525.8	µl	
Total	 	 	 4000	µl	
	
2.2.3.5	Genetic	inducers	
Two	 genetic	 inducers	 were	 used	 in	 the	 study.	 β-Estradiol	 (E2257,	 powder,	 γ-
irradiated,	BioXtra,	suitable	for	cell	culture)	was	purchased	from	Sigma-Aldrich.	The	
1000X	 stock	 solution	 (1mM)	was	made	by	 dissolving	 1mg	 in	 3.67	ml	 ethanol	 and	
stored	 at	 -20°C.	 Mifepristone/RU486	 (M8046)	 was	 also	 purchased	 from	 Sigma-






















































Reagent	 Stock	Concentration	 Final	Concentration	 Vol/25	µl	reaction	
dNTPs	 2.5	mM	 200	µM	 2.0	µl	 	
TPM	 300	nM	 30nM	 2.5	
Buffer	 10x	 1x	 2.5	µl	
Phu	 -	 -	 0.5	µl	









































Reagent	 Stock	Concentration	 Final	Concentration	 Vol/25	µl	reaction	
dNTPs	 2.5	mM	 200	µM	 2.0	µl	 	




Buffer	 10x	 1x	 2.5	µl	
Phu	 -	 -	 0.5	µl	
























throughput	 DNA	 amplification	 in	 the	 SynNP	 project;	 KAPA	 was	 used	 for	 difficult	
amplifications	including	high	GC	or	long	fragment	PCR	(>5	Kb)	and	PCRs	using	primers	
with	 inevitable	 secondary	 structures	 like	 the	 recombination	 sites.	Taq	polymerase	

































DNA	 fragments	 were	 first	 digested	 by	 restriction	 enzymes	 (NEB)	 and	 bands	 with	
expected	lengths	were	gel-extracted	and	purified	using	the	QIAquick	Gel	Extraction	

























for	 incubation	 in	a	 thermocycler:	55°C	 for	90min,	add	0.5	μl	T4	DNA	 ligase,	10-30	

























Color	 selection.	 Bacteria	 colonies	 expressing	 RFP	 have	 rose-carmine	 color	 after	 a	
certain	 time	 of	 culture.	 In	 order	 to	 accelerate	 the	 speed	 of	 color	 development,	
bacteria	with	the	RFP	gene	were	incubated	at	4°C	after	colonies	had	formed	at	37°C.	
For	clones	with	insert	containing	RFP,	red	colonies	were	picked	for	verification;	for	
clones	 with	 RFP	 as	 counter-selection	 marker,	 white	 colonies	 were	 picked	 for	
verification.		
Counter-selection	 with	 ccdB	 toxic	 gene.	 The	 ccdB	 gene	 was	 included	 in	 several	



















were	 set	up	as	 shown	 in	Table	2.16.	 	Bacterial	 colonies	were	picked	 from	culture	










Yeast	 colony	 PCR	 is	 similar	 to	 bacterial	 colony	 PCR.	 The	 difference	 is	 simply	 that	
boiling	yeast	will	not	efficiently	release	the	DNA	template	for	PCR.	Therefore,	yeast	
was	 pretreated	with	 20	mM	NaOH	 and	 boiled	 at	 95°C	 for	 10	min	 to	 be	 used	 as	
template.	Moreover,	the	annealing	time	was	extended	to	2	min/kb	in	yeast	colony	
PCR.	 Specifically,	 a	 96-well	 plate	 yeast	 colony	 PCR	 was	 performed	 for	 the	 SynII	
SCRaMbLE	PCR	tag	assay.	The	procedure	was	performed	as	follows.	A	sterile	pippet	
tip	was	used	to	pick	a	yeast	colony	and	handle	it	to	the	master	96-well	plate	in	one	
well	 containing	 50	 µl	 sterile	 (nuclease-free)	 ddH2O.		 The	 cells	 were	 re-suspended	





























For	 Single	 tube	miniprep,	 the	 experiment	was	 performed	 using	 the	QIAprep	 Spin	
Miniprep	Kit	according	to	the	manufacturer’s	instructions.		







Then	200	µl	 P2	 lysis	buffer	was	added	and	 the	plate	was	 tilted	carefully	as	 far	as	
possible	to	mix	the	cells	and	buffers.	The	mixture	was	incubated	for	1	or	2	min	for	


















glass	 beads	 and	 400	 µl	 of	 phenol:chloroform:isoamyl	 alcohol	 (25:24:1	 v/v)	 were	
added	to	each	tube	in	the	fume	hood	and	the	tubes	were	vortexed	for	10	min.	The	
mixture	was	centrifuged	at	17000	g	for	10	min	and	the	aqueous	phase	was	carefully	





ethanol	 at	 room	 temperature	 and	 then	 centrifuged	 at	 17000	 g	 for	 5	 min.	 The	










was	 added	 and	 the	 mixture	 was	 incubated	 in	 the	 -20°C	 freezer	 for	 10	 min.	 The	
mixture	was	centrifuged	at	17000g	for	10	min	and	the	supernatant	was	discarded.	











































The	 water	 bath	 was	 first	 equilibrated	 to	 42°C.	 The	 SOC.	 medium	 and	 LB	 plates	
containing	 corresponding	 antibiotics	 were	 warmed	 to	 room	 temperature.	 The	
competent	cells	were	thawed	on	ice	and	aliquoted	to	50	µl	for	each	transformation.	
10ng	 plasmid	 or	 half	 the	 volume	 of	 the	 cloning	 reaction	 was	 added	 into	 50	 µl	
competent	 cells	 and	 the	 mixture	 was	 incubated	 on	 ice	 for	 20-30	 min.	 After	 the	
incubation,	the	cells	were	heat-shocked	for	45	s	at	42°C	in	the	water	bath	(for	DNA	
	 -	60	-	










































use.	BY4741	was	 inoculated	 into	2	tubes	of	10	ml	of	 liquid	2	×	YPAD	medium	and	
cultured	overnight	on	a	shaker	at	200	r.p.m	at	30	°C.	A	bottle	of	500ml	2	×YPAD	and	
























boiled	at	100°C	for	5	min	and	chilled	on	 ice	 immediately.	A	360	µl	 transformation	
reaction	was	 set	 up	 for	 each	 sample	 as	 listed	 in	 Table	 2.21	 and	was	 used	 to	 re-
















Equal	 volume	of	30%	autoclaved	glycerol	 and	either	bacteria	or	 yeast	 cell	 culture	
growing	 in	 log	phase	were	mixed	well	and	stored	 in	 -80°C	 in	cryogenic	 tubes.	The	




















(Cat.	 No.:	 655101)	 were	 used	 for	 general	 growth	 curves,	 and	 BD	 Falcon	 96	 Flat	
Bottom	 Black	 Polystyrene	 plate	 (Cat.	 No.:	 353219)	 were	 used	 for	 fluorescence	
measurement.	The	parameters	were	as	follows:	culture	temperature	for	yeast	was	
30°C;	shaking	(linear)	duration	and	amplitude	were	550	s	and	6	mm;	kinetic	cycle	was	
180	 and	 multiple	 reads	 were	 recorded	 for	 mean	 calculation.	 Cell	 density	 was	




















































was	 inoculated	 to	10	ml	LB	media,	 supplemented	with	Kanamycin	 (50	μg/ml)	and	
incubated	overnight	at	37°C	with	shaking	at	180	r.p.m.	10	ml	of	the	overnight	pre-
culture	 was	 then	 transferred	 into	 a	 2.5	 L	 baffled	 flask	 with	 1	 L	 of	 LB	 medium	
supplemented	with	kanamycin	and	incubated	at	37	°C	with	shaking	at	180	r.p.m.	The	
cell	growth	was	monitored	by	recording	the	OD600	of	the	culture	at	regular	intervals	
and	 the	 recombinant	protein	production	was	 induced	at	 an	OD600	of	 0.6	with	 the	
addition	of	1	mM	IPTG.	 It	usually	took	around	2.5	h	to	reach	OD600	0.6;	 the	OD600	
should	 not	 exceed	 0.8	 to	 ensure	 a	 good	 protein	 expression.	 The	 incubation	
temperature	was	then	reduced	to	18°C	to	maximize	protein	expression	and	the	cells	
were	cultured	for	another	16	h.	An	alternative	induction	method	was	culturing	the	




at	 4oC,	 and	 re-suspended	 in	 10-fold	 (volume	 per	 gram	 of	 cell	 pellet)	 of	 PBS.	 The	









lysate	 was	 placed	 into	 a	 50	 ml	 polycarbonate	 centrifuge	 tube	 and	 clarified	 by	
centrifugation	at	35000	g	for	30	min	at	4oC.	The	resulting	cell	extract	was	filtered	with	
a	0.45	μm	syringe	filter	into	a	50	ml	falcon	tube.	Samples	from	both	the	supernatant	










while	 collecting	3	ml	 fractions	of	 the	elution.	As	 the	gradient	proceeded,	 the	A280	



























coefficient	 and	 molecular	 weight	 of	 the	 recombinases	 were	 obtained	 from	 the	
ExPASy	 database.	 The	 calculated	molar	 extinction	 coefficient	 of	 each	 protein	was	












In	 a	 100	 µl	 reaction,	 1	 µl	 10	 μM	 recombinase,	 1	 μg	 reporter	 DNA	 with	 target	


















Vlox	 or	 loxJTZ15	 promoter	 loading	 vector	 by	 BsmBI	 Golden	 Gate	 assembly.	 For	
promoter	 integration,	 the	 recombination	 reaction	 was	 set	 up	 by	 adding	 1.5	 μg	
promoter	mixture,	 800	ng	HO-Vlox-CrtI	 Carotene	 acceptor	 circuit	 or	HO-loxJTZ15-
VioA	violacein	acceptor	circuit,	10	μL	10X	recombination	buffer,	VCre	or	Cre	to	a	final	
concentration	of	100	nM,	and	ddH2O	to	100	μL.	The	reaction	was	incubated	at	37°C	

















at	 4°C.	 The	 supernatant	 was	 transferred	 to	 a	 fresh	 tube	 and	 600	 μl	 of	 ice-cold	
absolute	 ethanol	 was	 added	 to	 each	 well.	 The	 lysate/ethanol	 mixture	 was	 then	







samples	were	 spun	 at	 17000	 g	 for	 20	min	 at	 4°C.	 The	 supernatant	was	 carefully	
removed.	 	The	pellet	was	washed	with	200	μl	of	70%	v/v	ethanol	and	spun	down	
again	at	17000	g	for	1	min	to	remove	residual	ethanol.	The	pellet	was	dried	in	the	
vacufuge	 at	 30°C	 for	 30	 min	 (covered	 with	 a	 breathable	 seal)	 to	 remove	
any	remaining	 ethanol.	 The	 RNA	 was	 finally	 re-suspended	 in	 60	 μl	 ddH2O.	 The	





















for	 5	min	 at	 room	 temperature.	 The	 cells	were	 resuspended	 in	 100	ml	 SDS-PAGE	
sample	buffer	and	boiled	for	5	min	at	95°C	and	the	lysate	was	centrifuged	to	clear	
cellular	 debris.	 The	 supernatant	 containing	 yeast	 whole	 protein	 extract	 was	
transferred	to	a	fresh	tube	and	stored	at	-80	°C.	
• SDS-PAGE	and	membrane	transfer	
The	 concentration	 of	 the	 whole	 protein	 extraction	 was	 roughly	 estimated	 by	
NanoDrop.	The	protein	samples	(25-100	ng)	were	mixed	with	2X	SDS	loading	buffer	
and	 loaded	 into	 a	 Mini-PROTEAN™	TGX	 Stain-Free™	 Protein	 Gel	 (Bio-Rad).	 After	
running	at	150	V	for	40	min,	the	gel	was	pictured	by	UV	activation	in	a	Bio-Rad	Gel	





overnight	 at	4°C.	 Then	 the	membrane	was	 incubated	with	PBST-primary	antibody	
buffer	 (1:2000	 dilution)	 for	 3h	 at	 4°C.	 After	 the	 incubation,	 the	 membrane	 was	
washed	 three	 times	 with	 PBST	 for	 5	 min	 each	 wash.	 Then	 the	 membrane	 was	



























pellet	 was	 re-suspended	 in	 1	 ml	 of	 70%	 ethanol	 and	 left	 at	 RT	 for	 30	 min	 for	
permeabilization	of	membranes	and	counter-staining.	The	cells	were	spun	down	at	
13000	g	for	5	s	and	re-suspended	in	0.5	ml	water	and	be	sonicated	for	5	s	in	a	water	







DAPI/BFP,	 CFP,	 YPF,	 GFP/FITC/Alexa488/Cy2,	 TexasRed/mCherry	 were	 used	 for	
testing	 the	 fluorescence	 characters	 of	 carotenoid-producing	 yeast.	 Images	 were	
















and	 performed	 by	 the	 FACSAria	 cell	 sorter	(BD	 Biosciences).	 A	 13	 mW	 488	 nm	
coherent	Sapphire	laser	was	used	for	excitation	and	a	530/30	emission	filter	was	used	




























from	 230	 nm	 to	 700	 nm,	 was	 recorded	 where	 peaks	 were	 observed	 in	 the	
chromatogram.	
• Violacein	calibration	curve	









The	yeast	strains	were	cultured	 in	200	ml	 flasks	at	30	°C,	220	r.p.m,	 for	48	h.	The	












extraction.	 The	 vacuum-dried	 extracts	 were	 re-dissolved	 in	 isopropanol	 and	 the	
whole	mixture	was	cleared	by	ultrasonication.	The	cell	debris	was	spun	down	and	the	











min.	 The	parameters	 for	MS	were	 as	 follows.	 λ	 source/gas	 parameters:	 ion	 spray	
	 -	75	-	
voltage:	5500;	curtain	gas:	35,	nebulizer	gas	(gas	1)	55,	 ion	Source	GS2	(gas	2)	55;	




concentrations	 (2.50,	 1.00,	 0.75,	 0.50,	 0.20,	 0.10	 and	 0.05	 mg/L	 of	 commercial	



















menu	was	 performed;	 “light	 background”	 and	 “separate	 color”	with	 a	 rolling	 bar	
radius	of	10-30	pixels	was	selected	and	adjusted	depending	on	picture	quality.	For	






function	 in	 the	 Binary	menu	was	 performed	 to	 detach	 any	merged	 colonies.	 Any	
additional	 noise	 was	 removed	 using	 the	 paintbrush	 tool.	 Finally,	 the	 “Analyze	
Particles”	function	was	used	in	the	analyze	menu	to	calculate	the	colony	number.	The	
size	 option	 and	 shape	 option	were	 further	 adjusted	 to	 get	 rid	 of	 any	 non-colony	













medium	was	dispensed	 into	sterile	 test	 tubes	and	placed	 into	a	pre-warmed	48°C	
water	bath.	The	overlay	medium	was	cooled	to	48°C	for	more	than	15	min	to	prevent	
killing	 the	 test	 organism.	 The	 plates	with	 yeast	 growing	were	 pre-warmed	 in	 the	
incubator	and	taken	out	when	the	overlay	medium	was	ready.	The	tubes	with	overlay	
medium	were	removed	one	at	a	time	from	the	water	bath	to	avoid	cooling	too	fast	










with	 the	antibiotics	 to	be	put	on	 that	 location.	Under	 sterile	 conditions	 (with	 the	
Bunsen	burner)	and	using	tweezers,	the	appropriate	volume	of	antibiotics	was	added	








In	 the	design	of	 the	 synthetic	 yeast	 chromosomes,	 the	Cre/loxPsym	 recombination	





for	 the	 synthetic	 yeast	genome	 is	 to	 transfer	and	 isolate	 the	unstable	elements	–	




genome.	 In	 theory,	only	64	 tRNAs	with	corresponding	anti-codons	are	needed	 for	














polymerase	may	meet	 and	 collide	 and	 lead	 to	 single-strand	 breaks	 if	 the	 tRNA	 is	
transcribed	heavily	during	DNA	replication.	Moreover,	there	are	only	17	tRNA	genes	
on	average	in	each	chromosome	in	the	natural	yeast	genome;	so	we	can	see	whether	
there	will	 be	 any	 difference	 if	 all	 of	 the	 tRNA	 genes	 are	 put	 together	 in	 a	 single	
chromosome	 and	 whether	 the	 tRNA	 chromosome	 can	 be	 further	 evolved	 by	
SCRaMbLE.	 There	 could	 be	 problems	 of	 chromosome	 stability	 of	 the	 tRNA	
Neochromosome	 and	 SCRaMbLE	 could	 be	 used	 to	 select	 relatively	 more	 stable	
elements	and	improve	the	fitness.		
For	the	purpose	of	specific	SCRaMbLE	of	the	tRNA	Neochromosome,	an	orthogonal	
recombination	 system	 to	 Cre/loxP	 needs	 to	 be	 developed	 and	 fine-tuned	 for	







Neochromosome	 and	 normal	 synthetic	 chromosomes.	 Cre/loxP	 was	 used	 for	





including	 Dre/rox	 (Anastassiadis	 et	 al.,	 2009),	 Vika/Vox	 (Karimova	 et	 al.,	 2013),	
VCre/VloxP	(Suzuki	&	Nakayama,	2011),	SCre/SloxP	(Suzuki	&	Nakayama,	2011),	etc.	
There	are	many	conserved	domains	among	the	recombinases	while	still	recognizing	
unique	 target	 sequences	 (Figure	3.2	 and	Table	3.1).	 In	 this	 study,	 these	 four	new	
recombinases	 together	 with	 the	 well-studied	 Cre	 recombinase	 were	 chosen	 as	
candidate	 systems	 for	 the	 SCRaMbLE	 of	 synthetic	 chromosomes.	 Since	 the	
recombinases	 were	 originally	 from	 either	 bacteriophage	 or	Vibrio	 species,	 codon	
optimization	is	necessary	for	customized	efficient	expression	of	these	recombinases	
in	yeast.	Cre	was	amplified	by	PCR	from	a	CreEBD	expression	vector	from	a	previous	
study	 (Lindstrom	&	Gottschling,	2009);	Dre	was	 identified	 from	phage	D6	and	 the	
coding	 sequence	 was	 obtained	 from	 DDBJ/EMBL/GenBank	 database	 with	 the	
accession	number	AY753669	(Sauer	&	McDermott,	2004).	VCre	was	identified	from	
Vibrio	sp.	0908	and	the	sequence	was	obtained	 from	GenBank	with	 the	accession	















Name	 Target	site	 Length	 Site	sequence	
Cre	 loxP	 34	bp	 ATAACTTCGTATAGCATACATTATACGAAGTTAT	
Dre	 rox	 32	bp	 TAACTTTAAATAATTGGCATTATTTAAAGTTA	
VCre	 VloxP	 34	bp	 TCAATTTCCGAGAATGACAGTTCTCAGAAATTGA	
SCre	 SloxP	 34	bp	 CTCGTGTCCGATAACTGTAATTATCGGACATGAT	





whether	 the	 recombinases	 could	 actually	 drive	 recombination	 between	 target	
recombination	sites	(RS),	strong	expression	was	necessary;	for	SCRaMbLE	application,	
fine-tuned	moderate	 expression	 is	 necessary	 since	 excessively	 high	 expression	 of	
SSRs	will	lead	to	high	loss	rate	of	essential	genes	and	expression	at	too	low	a	level	
will	 not	 be	 enough	 to	 generate	 sufficient	 genome	 variation	 in	 a	 reasonable	 time	
period.	 For	 transcriptional	 regulation,	 different	 promoter	 and	 terminator	
























































DNA	 in	 the	 nucleus;	 the	 introduction	 of	 small	 hormone	 molecules	 will	 cause	
conformational	 change	 and	 interrupt	 the	 binding	 between	 LBD	 and	 heat	 shock	








marker	 (Figure	 3.4).	 Five	 reporter	 devices,	 for	 each	 recombination	 system,	 were	
constructed:	 pRS413-loxP-URA3-loxP,	 pRS413-rox-URA3-rox,	 pRS413-VloxP-URA3-
VloxP,	 pRS413-SloxP-URA3-SloxP	 and	 pRS413-Vox-URA3-Vox	 (Table	 3.3).	








on	 both	 SC-His-Leu	 and	 SC-His-Leu-Ura	 plates,	 a	 rough	 degree	 of	 recombination	
extent	can	be	estimated.	For	the	colonies	that	grow	on	SC-His-Leu	but	not	on	SC-His-
Leu-Ura,	 plasmid	 recovery,	 digestion	 verification	 and	 DNA	 sequencing	 were	
performed	to	finally	confirm	the	loss	of	the	URA3	unit	and	whether	recombination	
has	 taken	place	between	 the	 recombination	 sites.	 For	quantitative	 recombination	










Figure	 3.3	 |	 Tuning	 and	 control	 of	 recombinase	 function.	 a.	 Transcriptional	
regulation	of	recombinases.	Constitutive	and	inducible,	strong	and	weak	promoters,	
normal	 and	 mRNA	 stability-related	 terminators	 were	 used	 for	 tuning	 SSR	
transcriptional	 rate.	 b.	 Post-translational	 regulation	 of	 recombinases.	 Different	
hormone-binding	domains	 from	nuclear	 receptors	were	 fused	with	 SSRs	 for	 post-
translational	spatial	control	of	recombinase	function.	Hsp90:	heat	shock	protein	90.	




























































URA3	 cassette.	 Dre	 expression	 device	 was	 also	 used	 as	 control	 to	 rule	 out	 any	














without	the	1.2kb	band,	 indicating	the	 loss	of	URA3	 cassette	 for	all	 the	recovered	
plasmids.	The	Dre	expression	device	was	also	used	as	control	to	rule	out	recovered	
Dre	expression	plasmid.	 b.	Sequencing	 result	of	 recovered	 reporter	plasmids.	 The	







in	 a	 population,	 serial	 dilution	 and	 spotting	 assay	was	 performed	 on	 strains	with	
different	Dre-expressing	devices.	Strains	with	PTDH3-Dre	and	PSCW11-Dre	devices	were	
cultured	 overnight	 in	 SC-His-Leu	 glucose	 liquid	 culture	 and	 those	 with	 PGal1-Dre	
devices	were	cultured	in	SC-His-Leu	galactose.	They	were	then	spotted	on	SC-His-Leu	







with	 either	 TGal1	 or	 TMFA2	 and	 PSCW11-Dre	 with	 TMFA2.	 Strains	 with	 PGal1-Dre	 were	
cultured	 in	 galactose	 liquid	medium	 and	 the	 rest	 were	 cultured	 in	 glucose	 liquid	
medium	overnight.	The	spotting	result	shows	that	strains	with	reporter	devices	and	
pRS415	 empty	 vector	 grows	 well	 on	 both	 SC-His-Leu	 and	 SC-His-Leu-Ura	 plates;	
strains	with	all	Dre	expression	devices	grew	well	on	SC-His-Leu	devices	but	did	not	






half-life	of	 the	mRNA	did	not	 restrict	 the	 function	of	Dre.	This	 is	possibly	because	
although	the	level	of	expression	of	Dre	is	diversified,	the	timing	of	its	function	is	not	
controlled	 because	 PTDH3	 and	PSCW11	 are	 constitutive	 promoters	 but	 not	 inducible.	
Though	PGal1	is	inducible	by	galactose,	the	control	of	PGAL1	is	very	leaky-even	without	




Before	 introducing	 the	 hormone-induction	 of	 recombinase	 function,	 another	





























with	 Cre	 was	 also	 tested,	 it	 was	 time	 to	 enable	 hormone	 regulation	 of	 the	
recombination.	Dre	was	 fused	 to	 the	same	EBD	which	had	been	demonstrated	 to	








and	 release	 it	 by	 adding	 the	 hormones;	 then	 spotting	 assay	 was	 performed	 to	
quantitatively	 evaluate	 the	 induction	 efficiency.	 For	 the	 spotting	 assay,	 single	
colonies	were	inoculated	into	SC-His-Leu	liquid	medium	to	be	cultured	overnight.	For	
plate	 induction,	 the	 cells	were	 re-inoculated	 to	OD600	of	 1.0	 and	 spotted	 to	 three	
	 -	93	-	

































indicating	 the	 loss	 of	 the	 URA3	 cassette;	 the	 strains	 with	 PTDH3DreEBD	 and	
PSCW11DreEBD	grew	similarly	on	SC-His-Leu-Ura	plate	and	SC-His-Leu	plate	indicating	














plates	 than	 on	 the	 double	 dropout:	 strain	 with	 PTDH3-DreEBD	 has	 more	 than	 10	
colonies	on	double	dropout	while	it	has	6	colonies	on	triple	dropout	on	level	of	10-4	
dilution;	strain	with	PSCW11-DreEBD	have	7	colonies	on	double	dropout	plate	while	
have	only	 1	on	 triple	 dropout	plate	 (figure	 3.12a).	 Though	 the	 result	was	not	 yet	
conclusive	to	say	whether	the	induction	worked	or	not,	it	indicated	some	clues	that	
the	 induction	 might	 work	 better	 with	 longer	 induction	 and	 more	 concentrated	
inducer.	This	hypothesis	was	supported	by	the	plate	induction	result.	In	contrast	to	
liquid	induction,	the	plate	induction	is	always	on	during	colony	forming,	which	takes	
more	 than	 24	 h,	 normally	 2	 to	 3	 days.	We	 can	 see	 that	 on	 the	 1µM	b-estradiol	
containing	triple	dropout	plate,	the	colony	number	of	the	strain	with	empty	vector	is	
















The	 induction	 condition	 optimization	 for	 DreEBD	 includes	 timing,	 estradiol	
concentration	and	linker	modification	for	the	fusion	protein.			
Since	obvious	colony	 loss	 in	the	48h	plate	 induction	assay	was	observed,	different	











fold	 reduction	 (Figure	 3.13).	 Comparing	 the	 recombination	 efficiency	 of	 56h	
induction	in	the	1st	round	and	24h	induction	in	the	2nd	round,	I	found	that	although	
the	total	induction	time	is	the	same	(56h	in	total)	the	recombination	rate	of	2nd	round	
induction	 with	 re-inoculation	 and	 fresh	 b-estradiol	 is	 much	 higher	 than	 that	 of	
continuous	56h	 induction	 (Figure	3.13).	 Longer	 induction	 to	48	h	 in	 the	2nd	 round	
further	increased	the	recombination	rate	while	72h	induction	did	not	much	change	






















unit	 and	 become	 less	 efficient	 in	 driving	DNA	 recombination.	 Therefore,	 a	 higher	








(G)	 and	 aspartic	 acid	 (D)	were	 inserted	 at	 the	 joining	 location	 of	Dre	 and	 EBD	 to	
generate	a	new	fusion	version	PSCW11-Dre	(+GD)	EBD	with	a	5	aa	linker	(GDLEP).		For	
the	hormone	concentration	test	and	new	fusion	protein	test,	two	rounds	of	 liquid	








10µM	 b-estradiol	 have	 roughly	 104-fold	 colony	 number	 reduction	 and	
PSCW11Dre(+GD)EBD	 also	 have	 slightly	 greater	 reduction	 than	 PSCW11DreEBD	 (figure	
3.14).	The	result	illustrates	that	increased	concentration	of	b-estradiol	shows	a	slight	
	 -	99	-	
advantage	with	 longer	 time	 induction	over	 the	 lower	 concentration	and	modified	
DreEBD	fusion	protein	also	increased	the	recombination	efficiency	with	longer	time	
induction.	Though	 the	 two	methods	did	not	generate	a	huge	 improvement	of	 the	








Figure	 3.14|	 Induction	 result	 with	 different	 β-estradiol	 concentrations	 and	 a	











The	 function	 for	 CreEBD	 and	 DreEBD	was	 demonstrated,	 and	 the	 next	 step	 is	 to	
develop	another	hormone-inducible	recombinase	for	orthogonal	SCRaMbLE.	Cre	and	





and	 induced	by	RU486.	The	 replica	plating	assay	shows	 that	PBD	can	 restrain	Dre	
from	working	on	rox	sites	 in	 the	absence	of	RU486	but	can	barely	be	 released	by	
RU486	(Figure	3.15a).	The	spotting	assay	with	48h	plate	induction	is	consistent	with	
the	 replica	 plating	 result;	 no	 difference	 can	 be	 detected	 with	 or	 without	 RU486	
induction	(Figure	3.15b).	Therefore,	the	first	attempt	to	obtain	the	functional	DrePBD	











Figure	 3.15|	Function	 test	 of	DrePBD.	a.	 Replica	 plating	 result.	Not	much	 colony	
difference	was	 detected	on	 SC-His-Leu	 and	 SC-His-Leu-Ura	 plates	with	 or	without	














Two	 fusion	 proteins,	 DreEBD	 and	 CrePBD,	 have	 been	 designed	 and	 proved	 to	 be	
functional	with	b-estradiol	and	RU486	induction	respectively.	A	final	step	is	to	see	
whether	the	 inductions	of	 the	two	molecules	are	orthogonal	before	moving	on	to	
SCRaMbLE	 the	 synthetic	 chromosomes.	 Strains	 with	 the	 two	 reporter	 devices	





Figure	 3.17|	 Orthogonal	 induction	 test	 of	 CrePBD	 and	 DreEBD.	All	 strains	 were	
induced	by	either	1µM		b-estradiol	or	1µM		RU486	 in	 liquid	medium	for	43h.	The	
spotting	 assay	 shows	 that	 only	 the	 strain	 with	 loxPURA3loxP	 and	 PTDH3CrePBD	
induced	 by	 RU486,	 the	 strain	 with	 roxURA3rox	 and	 PTDH3DreEBD	 induced	 by	 b-
estradiol	 showed	 colony	 reduction	on	 the	 SC-His-Leu-Ura	plate.	 The	 result	 proves	














The	 above	 sections	 focused	 on	 the	 functional	 characterization	 of	 Dre.	 Here	 the	
function	of	other	backup	recombinases	is	introduced	to	explain	why	Dre	is	a	better	
candidate	 for	 the	orthogonal	SCRaMbLE	toolkit.	The	backup	recombinases	 include	




the	 pRS413-voxUravox	 device	 and	 PSCW11-Vika,	 and	 the	 strain	 with	 the	 pRS413-
SloxPUraSloxP	device	and	PSCW11-SCre	grew	well	on	the	SC-His-Leu	plate	but	failed	to	
grow	on	 the	SC-His-Leu-Ura	plate,	 indicating	 recombination	due	 to	Vika	and	SCre,	









with	 PSCW11VCreEBD	 was	 normal	 and	 similar	 to	 that	 transformed	 with	 pRS415,	
	 -	104	-	















Figure	 3.19|Colony	 size	 abnormality	 of	 strain	 with	 VCre	 expression	 device.	
Compared	with	the	strain	with	control	vector	pRS415,	the	strain	with	PSCW11VCre	had	
mostly	 petite	 colonies	 and	 some	 colonies	 with	 normal	 size,	 indicating	 potential	




































for	 plasmid	 recovery.	 Since	 there	 are	 only	 two	 XbaI	 sites	 outside	 the	 tRNA	 gene	
clusters,	the	recovered	plasmids	were	digested	with	XbaI	to	separate	the	tRNA	genes	





band	 but	 the	 size	 of	 the	 other	 band	 varies	 from	 0	 to	 3Kb,	 indicating	 partial	 or	
complete	loss	of	tRNA	genes	(Figure	3.21b).	Afterwards,	all	of	the	digestion	tested	
samples	 were	 sent	 for	 sequencing	 to	 get	 the	 full	 genotype	 information	 of	 the	
remaining	tRNA	genes.	The	sequencing	result	is	listed	in	figure	3.21c:	green	indicates	
that	the	tRNA	is	present	while	red	means	it	is	gone	(Figure	3.21c).	The	sequencing	
result	 is	 consistent	with	 the	 digestion	 result	 and	 random	 loss	 of	 tRNA	 genes	was	
observed.	However,	it	should	be	noted	that	with	or	without	estradiol	induction,	there	
is	tRNA	loss.	Four	out	of	seven	induced	isolates	lost	all	tRNA	genes	and	two	out	of	








was	 done	 in	 wild-type	 strain	 BY4741	 but	 not	 the	 synthetic	 strains	 which	 were	
knocked	out	for	the	tRNA	genes,	therefore	there	is	no	selection	pressure	on	the	tRNA	
genes	and	they	could	be	easily	lost.	It	is	not	clear	at	present	how	it	will	work	on	the	
fully	 synthesized	 tRNA	 Neochromosome	 since	 the	 number	 of	 rox	 sites	 in	 the	
Neochromosome	will	be	more	than	270	and	the	number	of	rox	sites	of	this	11-tRNA	
array	 could	 be	 much	 below	 the	 saturation	 point	 of	 Dre;	 furthermore,	 the	 tRNA	
Neochromosome	 will	 be	 put	 into	 a	 synthetic	 strain	 with	 selection	 pressure	 for	













the	 samples	 include	 one	 5Kb	 backbone	 band	 and	 a	 2nd	 band	 of	 different	 sizes,	
indicating	 various	 loss	 of	 tRNA	 genes,	 except	 for	 8-E	 which	 is	 the	 digestion	 of	
PSCW11DreEBD	plasmid.	Nega:	 negative	 control	 strain	with	 tRNA	 array	 and	pRS415	
vector.	N:	non-induced;	E:	estradiol	induced.		c.	Sequencing	analysis	of	SCRaMbLEed	
circular	 tRNA	 array.	Green:	 tRNA	 gene	 remains;	 Red:	 tRNA	 gene	 is	 lost.	 The	 loss	





In	 this	 section,	 the	 application	 of	 recombinase	 for	 SCRaMbLEing	 yeast	 synthetic	
chromosomes	will	be	introduced.	Before	using	the	engineered	CrePBD	designed	and	
constructed	 in	 this	 study,	 the	 published	 CreEBD	 device	 (Lindstrom	&	Gottschling,	
2009)	was	first	used	for	function	testing	on	synthetic	chromosomes.	The	first	partially	
















Figure	 3.22|	 SCRaMbLE	 function	 test	 of	 CreEBD	 on	 the	 strains	 with	 synthetic	
chromosomes.	BY4741,	SynIXR	and	SynII	were	used	to	 test	SCRaMbLE	 function	of	
CreEBD.	 In	plate	 induction,	BY4741	with	CreEBD	grew	well	while	SynIXR	and	SynII	






on	 SCRaMbLE	 of	 the	 synthetic	 yeast	 chassis	 for	 pathway	 diversification	 will	 be	
introduced.	 In	 addition	 to	 the	CrePBD	 SCRaMbLE	 test,	 a	 violacein-	 or	b-carotene-	
producing	pathway	was	also	introduced	into	the	synthetic	strain.	Violacein	is	a	violet	
pigment	that	has	antitumor	and	antibiotic	activities.	There	are	five	genes	involved	in	
the	pathway,	VioA,	B,	D,	C,	 E.	 In	 the	process	of	 violacein	production,	 some	green	
intermediates,	 prodeoxyviolacein	 and	 proviolacein,	 are	 produced	 before	 the	 final	
transformation	to	the	purple	violacein	(Lee	et	al.,	2013).	Therefore,	the	production	
stage	of	the	reaction	can	be	estimated	from	the	color	of	a	yeast	producer.		b-carotene	
is	 an	 orange	 pigment	 commercialized	 as	 food	 supplement.	 For	 the	 production	 in	
	 -	111	-	
yeast,	three	genes	were	introduced	including	CrtI,	CrtE,	CrtYB	(Verwaal	et	al.,	2007).	




with	 SCRaMbLEed	 synthetic	 strains.	 Mitchell’s	 work	 was	 referred	 to	 for	 the	
expression	of	the	two	pathways	in	yeast	(Table	3.4)	(Mitchell	et	al.,	2015).	With	the	
complete	 synthesis	 of	 more	 chromosomes,	 some	 synthetic	 chromosomes	 were	
combined	 together	 by	 collaborators	 from	 New	 York	 University,	 and	 Tsinghua	
University,	 including	 SynIII-VI-IXR	 and	 SynII-XII.	 We	 were	 also	 gifted	 with	 a	 SynV	


























Strain	ID	 Description	 Genotype	 Source	
LWy095	 SynII	1.3	 leu2∆0	met15∆0	LYS2	ura3∆0	his3∆1	 Cai	 Lab	
(UoE)	
LWy096	 SynIII-VI-IXR	 leu2∆0	lys2∆0	MET15	ura3∆0	his3∆1	synIII	















RU486	 induction,	 the	 cells	 were	 also	 plated	 at	 certain	 time	 points	 to	 screen	 for	
colonies	that	have	color	variations.	The	candidate	colonies	were	further	streaked	out	




BY4741	 with	 violacein	 is	 darker	 than	 SynII-XII	 and	 there	 is	 not	 much	 difference	
between	the	SynII-XII	control	strains.	For	the	SCRaMBLEed	strains,	some	have	lighter	






pRS415,	 SynII-XII	 strain	with	 pRS415	 and	 SynII-XII	 with	 PTDH3CrePBD-pRS415	were	
used	for	the	induction	and	spotting	assay.	The	former	two	were	controls.	Cells	were	
spotted	to	SC-Ura-Leu	plates	after	24h	and	48h	RU486	induction	respectively.	Only	















variation	 is	 different	 among	 these	 SCRaMbLEed	 synthetic	 strains	 (Figure	 3.25).		







to	 give	a	 selection	pressure	 to	obtain	 the	SCRaMbLEed	 strains	more	efficiently.	A	
SCRaMbLE	 selection	 strategy	 will	 be	 introduced	 in	 the	 next	 chapter	 followed	 by	
deeper	chemical	analysis	and	genotype	analysis	on	the	SCRaMbLEed	strains.		
																			 	
Figure	 3.25|	 Color	 comparison	 between	 SCRaMbLEed	 synthetic	 strains	 with	 b-








five	 candidate	 recombinases,	 Cre	 and	 Dre	 were	 proven	 to	 be	 the	 best	 two	
recombinases	for	SCRaMbLE	and	their	recombination	functions	are	orthogonal.	Cre	





Since	 the	 tRNA	 Neochromosome	 was	 not	 fully	 synthesized	 and	 has	 not	 been	
characterized,	the	function	of	DreEBD	was	only	tested	on	a	partially	synthesized	tRNA	
	 -	116	-	
array.	 Though	 more	 induction	 optimization	 should	 be	 done	 for	 the	 tRNA	
Neochromosome	in	future,	DreEBD	was	proved	to	generate	random	tRNA	loss	in	the	
tRNA	 array.	 For	 the	 SCRaMbLE	 of	 normal	 synthesized	 chromosomes,	 CrePBD	was	
used	 to	 SCRaMbLE	 SynIXR,	 SynII,	 SynV,	 SynII-XII	 and	 SynIII-VI-XI.	 Pathway	
diversification	was	initially	tested	by	SCRaMbLEing	these	synthetic	strains	with	two	
demonstration	 pathways:	 violacein	 and	b-carotene	 synthesis	 pathways.	 Now,	 the	










Chapter	 4	 Chassis	 level	 pathway	 diversification	 in	 synthetic	
yeast	
4.1	Overview	and	circuit	design	





The	main	 strategy	 for	 optimizing	 heterologous	 pathways	 includes	 fine-tuning	 the	
expression	 level	 of	 each	 gene	 in	 the	 pathway,	 while	 the	 genomic	 context	 of	 the	
heterogeneous	chassis	is	also	of	vital	importance.		Local	host	pathways	can	compete	
with	heterologous	pathways	 for	 precursors	 and	energy	molecules.	 Lowering	 gene	
expression	 in	 competing	 pathways	 or	 deleting	 genes	 interacting	 with	 the	 target	
pathway	can	re-direct	precursor	fluxes	or	remove	toxicity	of	side	products	to	achieve	
higher	target	production.	However,	deleting	local	genes	could	also	affect	the	fitness	
of	 the	 host	 cell.	 Simultaneous	 whole	 genome	 optimization	 has	 the	 potential	 to	










activation	of	Cre	 recombinase	 (SCRaMbLE).	The	synthetic	yeast	 is	used	 for	chassis	
optimization	 of	 expression	 of	 heterologous	 pathways.	 A	 universal	 SCRaMbLE-in	
device	 was	 designed	 to	 integrate	 any	 pathway	 of	 interest	 into	 the	 synthetic	
chromosomes.	 The	 b-carotene	 and	 violacein	 synthesis	 pathways	 were	 used	 for	
demonstrating	pathway	integration	by	the	SCRaMbLE-in	device.	
	
In	 the	 synthetic	 yeast	 genome	 Sc	 2.0	 project,	 the	 SCRaMbLE	 system,	 Synthetic	
Chromosome	 Recombination	 and	 Modification	 by	 LoxP-Mediated	 Evolution,	 was	
designed	 to	 introduce	genome-wide	LoxPsym	sites	and	can	generate	 theoretically	
nearly	infinite	gene	order	permutations	(Dymond	et	al.,	2011).	This	design	was	seen	
as	the	most	intriguing	and	potentially	valuable	design	change	added	to	the	synthetic	
genome	 (Jovicevic	 et	 al.,	 2014;	 Shen	 et	 al.,	 2016).	With	 the	 continuing	 successful	
synthesis	and	construction	of	these	synthetic	chromosomes,	their	stable	existence	
and	 minimal	 effect	 on	 phenotypes	 (Annaluru	 et	 al.,	 2014;	 Mercy	 et	 al.,	 2017;	
Richardson	et	al.,	2017;	Shen	et	al.,	2017),	the	synthetic	yeast	can	be	a	unique	novel	
platform	 for	metabolic	 engineering.	 In	 addition	 to	 the	 genomic	 composition,	 the	
location	of	integration	could	affect	the	transcription	efficiency	differently	depending	







favors	 stable	 replication	 and	 expression	 in	 the	 host.	 Though	 the	 effect	 of	 some	
locations	in	the	genome	has	been	characterized	(Englaender	et	al.,	2017;	Flagfeldt,	
Siewers,	Huang,	&	Nielsen,	 2009),	 this	 characterization	 has	 not	 yet	 systematically	







et	 al.,	 2017).	 The	 loxPsym	 site	 (ATAACTTCGTATAATGTACATTATACGAAGTTAT)	 is	 a	
symmetrical	 spacer	mutant	 of	 loxP	 (Hoess	 et	 al.,	 1986)	 and	when	 the	 SCRaMbLE	






designed	 to	 achieve	 SCRaMbLE-in	 to	 any	 synthetic	 chromosome	when	 the	whole	
genome	 synthesis	 is	 completed.	 The	 SCRaMbLE-in	 device	was	 constructed	 from	a	
yeast	 centromeric	 plasmid	 to	 control	 the	 copy	 number,	 and	 includes	 a	 YeastFab	
compatible	 BsaI	 sites	 flanking	 an	 RFP	 cassette	 for	 pathway	 loading,	 a	 LEU2	
auxotrophic	marker	for	integration	selection	between	two	loxPsym,	sites	and	a	URA3	
counter	selection	marker	(Figure	4.2).	When	recombinase	is	expressed	in	yeast,	the	
pathway	 is	 first	 excised	 from	 the	 device	 and	 then	 integrated	 into	 the	 synthetic	
	 -	120	-	
genome.	 A	 URA3	 counter-selection	 strategy	 was	 used	 for	 screening	 genome	
integrated	 strains.	 With	 the	 expression	 of	 URA3,	 the	 substrate	 5-FOA	 can	 be	
converted	 to	 the	 toxic	 form	 (i.e.,	5-fluorouracil).	 If	 recombination	does	not	occur,	
plasmid-bearing	 cells	 will	 die	 because	 of	 the	 presence	 of	 the	 URA3	 gene;	 if	








Figure	 4.2|Design	 and	 selection	 strategy	 of	 the	 SCRaMbLE-in	 device.	 The	
SCRaMbLE-in	device	is	based	on	a	yeast	centromeric	plasmid	with	URA3	marker.	A	
BsaI	 site-flanked	RFP	 cassette	 and	 a	 LEU2	 expression	unit	were	put	 between	 two	
loxPsym	sites.	LEU2	is	used	as	positive	selection	marker	for	integration	and	URA3	is	












plate	are	potential	 SCRaMbLE-in	 candidates,	but	 they	need	 further	 verification	by	
colony	 PCR	 of	 the	URA3	 region,	 to	 ensure	 the	 absence	 of	URA3	 rather	 than	 its	
inactivation	by	point	mutation.	The	verified	 integrants	are	characterized	either	by	
flow	cytometry	for	the	GFP	cassette	integration	or	by	chemical	analysis	for	pathway	
integration.	 For	 those	 with	 interesting	 phenotypes,	 the	 integration	 location	 and	
whole	genome	variation	are	confirmed	with	next	generation	sequencing.	Finally,	the	
contributions	of	genotype	variations	to	phenotype	variations	can	be	further	analyzed	
and	 investigated.	 Genome	 integration	 is	 one	 aspect	 of	 SCRaMbLE-in;	 continuous	




































































golden	 gate	 assembly	 for	 expression	 in	 the	 synthetic	 strain.	 The	 fluorescence	























To	 enable	 high-throughput	 screening	 of	 high	 GFP-expressing	 strains	 from	 a	 large	
population,	the	FACS	method	was	tested	on	LWy245,	a	SynII	strain	with	the	PTDH3-GFP	















cells	 were	 selected	 from	 the	 top	 and	 bottom	 12%	 of	 the	 GFP	 expressing	 cells	
respectively.	b.	Fluorescence	comparison	between	recovered	High	GFP	and	Low	GFP	
sorted	cells.	The	High	GFP	and	Low	GFP	population	were	sorted	out	and	recovered	
on	 SC-Leu	 plates.	 By	 photographing	 with	 the	 Bio-Rad	 Gel	 Doc	 system,	 the	
fluorescence	 of	 the	 recovered	 yeast	 colonies	 was	 recorded	 and	 compared.	 c.	







Some	recovered	colonies	were	picked	 individually	 for	 further	quantification	of	the	
fluorescence	intensity.	The	result	shows	that	colonies	from	the	High	GFP	population	





High	 GFP	 population	 for	 continuous	 SCRaMbLE	 and	 sorting	 to	 see	 whether	 after	







for	 heterologous	 pathway	 expression,	 an	 automated	 screening	method	 for	 target	
chemical	 product	 is	 also	 worth	 exploring.	 Taking	 the	 b-carotene	 pathway	 as	 an	
example,	 it	was	reported	 in	a	previous	study	that	 the	carotenoid-expressing	yeast	
showed	fluorescence	and	the	excitation/emission	wavelength	were	similar	to	those	
of	GFP	 (An,	 Bielich,	Auerbach,	&	 Johnson,	 1991).	 Based	on	 that,	 the	 fluorescence	
distribution	of	carotenoid	producing	yeast	was	tested	with	fluorescence	microscopy	
and	flow	cytometry.	The	microscopy	result	shows	that	there	are	fluorescent	spots	
distributed	 unevenly	 in	 the	 carotenoid-producing	 cells	 under	 the	 YFP	 and	 FITC	
channel	 (Figure	 4.6a).	 The	 formation	 of	 these	 particles	 could	 be	 because	 of	 the	
aggregation	of	the	hydrophobic	carotenoids	in	the	cellular	environment.		Next,	the	
fluorescence	 distribution	 of	 different	 carotenoid	 production	 strains,	 which	 were	
generated	with	the	in	vitro	DNA	recombinase	toolkit	that	will	be	described	in	Chapter	
5,	were	compared.	From	LWy068	to	LWy076,	the	degree	of	orange	color	gradually	













Figure	 4.6|Fluorescence	 measurement	 of	 carotenoids	 in	 yeast.	 a.	 Fluorescence	
microscopy	of	carotenoid	producing	yeast.	Fluorescent	spots	can	be	observed	in	the	
YFP	 and	 FITC	 channel.	Wild	 type	 strain	 BY4741	 was	 used	 as	 negative	 control.	 b.	
Fluorescence	 distribution	 of	 various	 carotenoid-producing	 yeast	 cells	 by	 flow	
cytometry.	The	fluorescence	peak	of	the	wild	type	control	strain	and	the	most	orange	
carotenoid	 producing	 strain	 are	 separated	 but	 there	 is	 a	 big	 overlap	 of	 the	
distributions,	 shown	 in	 the	 upper	 panel.	 Nine	 more	 yeast	 strains	 with	 different	







device	was	 characterized	 at	 the	 same	 time.	 Based	 on	 the	 universal	 SCRaMbLE-in	
acceptor,	five	SCRaMbLE-in	devices	were	constructed:	b-carotene,	violacein,	PTDH3-
GFP,	PACT1-GFP	and	PYGR270W-GFP.	 The	genetic	 compositions	of	 the	b-carotene	and	
	 -	128	-	
violacein	 pathways	 are	 as	 described	 in	 chapter	 3	 (Table	 3.4).	 As	 described	 in	 the	

















the	 efficiency	 of	 SCRaMbLE-in	 is	 better	 under	 24h	 induction	 than	 12h	 induction;	
SCRaMbLE-in	process	driven	by	PTDH3-CreEBD	is	slightly	faster	than	PSCW11-CreEBD	but	
also	has	a	stronger	negative	effect	on	the	fitness	of	the	synthetic	strain;	the	growth	
status	of	 the	strains	were	not	synchronized	which	 indicates	 that	 the	SCRaMbLE-in	
process	happens	randomly	during	the	activation	of	recombination.	Therefore,	for	the	
pathway	SCRaMbLE-in	experiment	PSCW11-CreEBD	was	used	considering	the	burden	
of	 the	 heterologous	 expression	 of	 the	 pathway	 and	 PTDH3-CreEBD’s	 effect	 on	 the	
fitness	of	the	synthetic	yeast.	The	induction	time	also	increased	to	24h	and	48h	for	
the	spotting	assay.	The	result	shows	that	the	number	of	survivors	on	the	5-FOA	plate	
after	 24h	 induction	 was	 similar	 to	 that	 of	 the	 GFP	 SCRaMbLE-in;	 the	 number	 of	
survivors	on	the	5-FOA	plate	after	48h	induction	was	similar	to	that	on	SC-Leu	plate,	




for	 PCR	 verification.	 The	plating	 result	 shows	 that	 the	 colony	 size	 and	 color	were	
diversified.	Though	they	were	not	extremely	diversified	in	this	round	of	induction	it	












5-FOA	 plate.	 	 b.	 Spotting	 assay	 result	 for	 pathway	 SCRaMbLE-in.	 Cre	 expression	
device	PSCW11-Cre	was	used	for	pathway	SCRaMbLE-in.	With	24h	and	48h	induction,	
cells	 grew	 on	 the	 5-FOA	 plate.	 A	 few	 colonies	 grew	 on	 the	 5-FOA	 plate	 for	 the	
negative	 control,	 which	 could	 be	 due	 to	 the	 long	 sequence	 of	 the	 pathway	 and	











spotting	 assay	 also	 shows	 that	 the	 colors	 of	 the	 samples	of	 either	 violacein	or	b-
carotene	are	varying	from	the	original	control	sample	(Figure	4.8a).	To	ensure	the	












the	 violacein	 strains,	which	 could	 be	 due	 to	 the	 larger	 size	 of	 the	 violacein	 gene	
cluster	(Figure	4.8c).	To	this	end,	preliminary	tests	of	all	the	selected	SCRaMbLE-in	
candidates	were	done	and	those	with	negative	signals	for	PCR	tags	were	forwarded	










Strains	which	 passed	 the	 initial	 PCR	 tag	 verification	were	 sent	 for	whole	 genome	
sequencing	in	Beijing	Genomics	Institute	(BGI).	The	sequencing	results	show	that	the	
whole	 violacein	 and	 b-carotene	 pathway	 can	 be	 integrated	 to	 the	 synthetic	





HIS3	 locus	 on	 Chromosome	XV.	 The	 locations	 of	 integration	 on	 SynII	 are	 204640,	






darker	 color	 were	 selected	 and	 sent	 for	 NGS	 and	 these	 locations	 could	 enhance	
pathway	expression	and	production.	The	chemical	analysis	of	 these	strains	will	be	
introduced	in	the	next	section.	Besides	pathway	integration,	other	genome	variations	
including	 deletion,	 inversion	 and	 duplication	 were	 also	 observed.	 Among	 these	
strains,	 LWy238	 has	 the	most	 dramatic	 and	 complicated	 genome	 rearrangement	
(Figure	 4.9b).	 Besides	 simple	 inversion	 and	 deletion,	 the	 genome	 of	 LWy238	
increases	 around	 394Kb	 in	 length,	 including	 2	 to	 7	 copies	 of	 certain	 fragments	
between	regions	from	297781	to	720928	(Figure	4.9c).	Since	the	duplicated	area	is	
large	 and	 the	 variation	 pattern	 is	 very	 complicated,	 the	 DNA	 order	 can	 only	 be	
narrowed	down	to	72	possible	combinations;	one	order	is	displayed	in	Figure	4.9c.	
The	 selection	 of	 SCRaMbLE-in	 strains	 added	 pressure	 and	 complicated	 genome	










a.	 Violacein	 SCRaMbLE-in	 -	 LWy152
	












































Figure	 4.9|Whole	 genome	 sequencing	 of	 the	 SCRaMbLE-in	 strains.	 a.	 LWy152,	
violacein	 pathway	 integrated	 to	 the	 loxPsym	 site	 at	 position	 204640,	with	 217bp	
deletion	from	position	540233	to	540450.		b.	LWy238,	violacein	pathway	integrated	
to	the	loxPsym	site	at	position	212908,	with	a	13kb	inversion	from	121692	to	134777,	















the	 chemical	 composition	 and	 production	 of	 the	 SCRaMbLE-in	 variants	were	 also	
characterized	and	quantified.		To	quantify	the	production	of	violacein	and	the	two	
major	 carotenoids,	 b-carotene	 and	 lycopene,	 commercial	 standards	 of	 the	 three	
products	were	purchased.	HPLC	was	used	for	violacein	quantification	and	LCMS	was	
used	 for	 b-carotene	 and	 lycopene	 quantification.	 With	 proper	 dilution,	 standard	
	 -	136	-	
curves	were	made	 for	 the	 three	 chemicals	 (Figure	 4.10).	 Chemical	 extraction	 and	
quantification	for	the	five	NGS	confirmed	SCRaMbLE-in	strains	were	carried	out	with	
the	 same	 HPLC	 or	 LCMS	 method	 described	 in	 section	 2.13.	 Strain	 LWy134	 and	









of	 b-carotene	 and	 lycopene	 among	 the	 SCRaMbLE-in	 strains.	 For	 LWy215,	 the	
quantity	of	both	b-carotene	and	lycopene	is	reduced;	for	LWy252,	the	quantity	of	b-
carotene	 is	 increased	 to	 twice	 of	 that	 of	 the	 control	 strain	while	 the	 quantity	 of	
lycopene	 is	 slightly	 reduced,	 indicating	 higher	 transformation	 efficiency	 from	
lycopene	to	b-carotene;	for	LWy253,	though	the	total	carotenoid	quantity	is	reduced	
to	 half,	 the	 yield	 of	b-carotene	 is	 similar	 to	 that	 of	 the	 control	 strain,	which	 also	
indicates	a	higher	transformation	rate	of	lycopene	to	b-carotene.	Both	the	genotype	
and	phenotype	were	thus	characterized	for	the	SCRaMbLE-in	strains	and	proven	to	
be	 diversified	 by	 the	 activation	 of	 Cre	 recombinase.	 The	 effects	 of	 genome	
integration	 and	 genome	 rearrangement	 by	 SCRaMbLE	were	 different	 for	 the	 two	







































































carotenoids	 and	 b-carotene.	 LWy215	 has	 slightly	 lower	 production	 of	 total	
carotenoids	and	b-carotene	than	HO-integrated	control	strain.	LWy253	has	half	the	









to	 generate	 more	 genome	 variants	 and	 to	 screen	 for	 mutants	 with	 even	 higher	
production.	Strains	with	lower	production	are	also	interesting	to	look	into	since	we	
























its	 ratio	 with	 the	 intermediate	 proviolacein	 were	 quantified	 for	 the	 continuous	










of	 characterization.	 For	 the	 downregulated	 strains,	 LWy152-	 and	 LWy238-,	 their	
violacein	production	was	reduced	to	around	0.5	mg/L,	which	is	almost	1/10	of	the	
production	of	either	LWy152	or	LWy238;	the	yield	of	LWy239-	is	reduced	to	3.5mg/L	
but	 is	 not	 as	 dramatically	 reduced	 as	 LWy152-	 and	 LWy238-.	 As	 to	 the	 ratio	 of	






Figure	 4.13|HPLC	 quantification	 of	 violacein	 continuous	 SCRaMbLEed	 strains.	 a.	
Chromatograms	of	multiple	continuous	SCRaMbLEed	strains	with	HPLC.	The	graph	
was	plotted	for	multiple	strains	for	easier	comparison	of	the	chemical	compositions	
between	 the	 mutants.	 The	 absorbance	 was	 measured	 at	 575mm,	 which	 is	 the	
absorption	peak	 for	violacein.	b.	Quantification	of	violacein/proviolacein	ratio	and	
violacein	 production.	 The	 violacein/proviolacein	 ratio	 is	 shown	 in	 grey	 and	 the	
violacein	production	is	shown	in	purple.	The	conversion	efficiency	of	proviolacein	to	
violacein	and	the	violacein	yield	were	all	confirmed	to	be	diversified	by	continuous	
SCRaMbLE.	 Strain	 LWy152+	was	 upregulated	 from	 the	 LWy152	 strain	 after	 conti-









chromosome	 is	 putting	 PCRtagging	 watermarks	 in	 the	 genome	 to	 distinguish	 the	
synthetic	 sequence	 from	 the	 wild	 type	 sequence,	 a	 library	 of	 PCR	 primers	 were	


































Figure	 4.14|Synthetic	 PCR	 tag	 verification	 of	 the	 continuous	 SCRaMbLE	 strains.	
LWy152	has	no	missing	tags;	LWy152+	has	a	missing	tag	at	YBR296C	and	a	modified	
tag	 at	 YBR014C;	 LWy152-	 has	 a	 missing	 tag	 at	 YBR044C;	 LWy238,238+,238-,239,	
239+,239-	all	have	a	missing	tag	at	YBR250W;	LWy238-	has	two	extra	missing	tags	at	








a	 gene	 complementation	 experiment	was	 done	 on	 the	 two	 strains.	 The	 YBR044C	
transcription	unit	was	cloned	to	both	the	low-copy	centromeric	vector	pRS413	and	
the	high-copy	episomal	vector	pRS423	for	transformation	back	to	the	SCRaMbLEed	
strains.	 The	 purpose	 of	 putting	 high-copy	 cloned	 YBR044C	 is	 to	 see	 whether	
overproduction	 of	 the	 related	 deleted	 gene	 could	 improve	 the	 production	 of	
violacein.	 Together	 with	 a	 negative	 control	 vector	 pRS413,	 the	 two	 YBR044C	
	 -	145	-	
constructions	 were	 transformed	 to	 LWy152,	 152+,	 152-,	 238	 and	 238-	 for	 color	
comparison.	Two	colonies	from	each	transformation	were	picked	and	spotted	with	a	




to	 LWy152	 and	 LWy152+	 did	 not	 darken	 the	 color	 of	 the	 two	 strains;	 the	
overproduction	of	YBR044C	did	not	improve	the	violacein	yield	but	added	burden	to	
the	cell	(Figure	4.15).	Nonetheless,	the	complementation	experiment	shows	that	the	
contribution	 of	 various	 genome	 rearrangements	 to	 a	 phenotype	 change	 by	
SCRaMbLE	can	be	narrowed	down	through	detecting	shared	deleted	tags	and	can	be	
attempted	for	testing	other	types	of	genome	variation	in	future	with	the	NGS	data.	
The	 standard	 name	 of	 YBR044C	 is	 TCM62,	 which	 is	 a	 mitochondrial	 membrane	
protein	 and	 a	 putative	 chaperone	 involved	 in	 the	 assembly	 of	 the	 succinate	
dehydrogenase	(SDH)	complex	(Dibrov,	Fu,	&	Lemire,	1998).	The	deletion	of	TCM62	
won’t	affect	the	viability	of	the	cell	but	can	interrupt	the	function	of	SDH	and	further	
affect	 the	 tricarboxylic	 acid	 cycle	 and	 the	 mitochondrial	 respiration	 chain	 in	 S.	
cerevisiae.	As	to	how	the	deletion	of	YBR044C	results	in	reduced	violacein	production,	
a	 potential	 explanation	 could	 be	 that	 the	 violacein	 synthesis	 process	 is	 NADPH-





LWy152-	 and	 LWy238-,	 YBR185C	 that	 is	 the	 sole	 deletion	 in	 LWy239-,	 encoded	 a	
membrane-associated	mitochondrial	 ribosome	 receptor.	 The	 deletion	 of	 YBR185C	
can	affect	the	process	of	mitochondrial	translation,	which	probably	further	interrupts	





Figure	 4.15|YBR044C	 complementation	 result.	 LWy152-	 and	 LWy238-	 have	 the	
same	 YBR044C	 deletion.	 LWy152-	 and	 LWy238-	 complemented	 with	 pRS413-
YBR044C	recovered	the	phenotype	as	the	LWy152	and	LWy238	strain	respectively.	
Transformation	 of	 pRS413-YBR044C	 into	 LWy152,	 LWy152+	 and	 LWy238	 did	 not	





The	 PCR	 tag	 assay	 is	 a	 fast	way	 of	 detecting	 fragment	 deletion	 but	 for	 fragment	
duplication,	 inversion	or	translocation,	whole	genome	sequencing	is	still	necessary	
for	 confirming	 all	 variations.	 The	 genome	 rearrangements	 for	 the	 source	 strains	
generated	by	SCRaMbLE-in	and	continuous	SCRaMbLEed	strains	are	summarized	in	
Table	4.3.	The	results	show	that	besides	the	deletion	detected	with	the	PCR	tag	assay,	
there	 are	more	 complex	 genome	 rearrangements	 in	 the	 continuous	 SCRaMbLEed	
strains,	 including	 deletions	 of	 UTR	 regions,	 inversions	 and	 duplications.	 Since	 the	
loxPsym	sites	were	all	located	outside	CDS,	the	inversion	of	fragments	normally	only	
switches	 the	 UTR	 regions	 of	 two	 genes,	 which	 could	 have	 minor	 impact	 on	 the	
expression	 level	 of	 the	 genes.	 The	 deletion	 of	 3’UTR	 regions	 will	 also	 affect	 the	
expression	 level	 of	 genes.	 The	duplication	of	 a	CDS	will	 affect	 its	 expression	 level	
while	 the	deletion	of	a	CDS	will	 lead	 to	 total	 function	 loss	of	 the	gene	and	might	
trigger	consequent	changes	in	metabolic	fluxes.	The	additional	genome	variations	of	
the	continuous	SCRaMbLEed	strains	provide	information	on	candidates	that	can	be	
related	 to	 the	 change	 of	 phenotype	 and	 further	 experiments	 such	 as	 gene	














SynII	1.3	 204640	 204673	 INS	
pWL046	 2067	 15345	 INS_fragment	
SynII	1.3	 540233	 540450	 DEL	
LWy256	
(LWy152+)		
SynII	1.3	 204640	 204673	 INS	
pWL046	 2067	 15345	 INS_fragment	
SynII	1.3	 204115	 204673	 INV	
SynII	1.3	 215628	 216620	 INV	
SynII	1.3	 236489	 237846	 DEL	
SynII	1.3	 240777	 241151	 INV	
SynII	1.3	 540233	 540450	 DEL	
SynII	1.3	 619127	 619127	 INV	
LWy257	
(LWy152-)	
SynII	1.3	 204640	 204673	 INS	
pWL046	 2067	 15345	 INS_fragment	
SynII	1.3	 134556	 134777	 DEL	
SynII	1.3	 240777	 241151	 DEL	
SynII	1.3	 260766	 261157	 INV	
SynII	1.3	 295260	 297781	 DEL	
SynII	1.3	 540233	 540450	 DEL	
SynII	1.3	 591520	 593811	 INV	
SynII	1.3	 614390	 615200	 DEL	
LWy238		
SynII	1.3	 212908	 212941	 INS	
pWL046	 15345	 2067	 INS_fragment	
SynII	1.3	 121692	 134777	 INV	
SynII	1.3	 297748	 716070	 DUP	
SynII	1.3	 297748	 317917	 DUP	
	 -	148	-	
SynII	1.3	 690041	 720961	 DUP	
SynII	1.3	 297748	 298280	 DUP	
SynII	1.3	 300615	 307392	 DUP	
SynII	1.3	 307359	 317917	 DUP	
SynII	1.3	 403656	 439168	 INV	
SynII	1.3	 581558	 624877	 INV	
SynII	1.3	 686278	 690074	 DEL	
SynII	1.3	 732447	 732697	 DEL	
LWy258	
(LWy238+)	
SynII	1.3	 212908	 212941	 INS	
pWL046	 15345	 2067	 INS_fragment	
SynII	1.3	 121692	 134777	 INV	
SynII	1.3	 297748	 716070	 DUP	
SynII	1.3	 297748	 317917	 DUP	
SynII	1.3	 690041	 720961	 DUP	
SynII	1.3	 297748	 298280	 DUP	
SynII	1.3	 300615	 307392	 DUP	
SynII	1.3	 307359	 317917	 DUP	
SynII	1.3	 403656	 439168	 INV	
SynII	1.3	 453559	 469144	 INV	
SynII	1.3	 562415	 562728	 INV	
SynII	1.3	 562415	 573406	 Tandem_Dup	
SynII	1.3	 581558	 624877	 INV	
SynII	1.3	 686278	 690074	 DEL	
SynII	1.3	 732447	 732697	 DEL	
LWy259	
LWy238-)	
SynII	1.3	 212908	 212941	 INS	
pWL046	 15345	 2067	 INS_fragment	
SynII	1.3	 121692	 134777	 INV	
SynII	1.3	 292761	 298280	 DEL	
SynII	1.3	 297748	 716070	 DUP	
	 -	149	-	
SynII	1.3	 297748	 317917	 DUP	
SynII	1.3	 690041	 720961	 DUP	
SynII	1.3	 297748	 298280	 DUP	
SynII	1.3	 300615	 307392	 DUP	
SynII	1.3	 307359	 317917	 DUP	
SynII	1.3	 403656	 439168	 INV	
SynII	1.3	 581558	 624877	 INV	
SynII	1.3	 686278	 690074	 DEL	
SynII	1.3	 732447	 732697	 DEL	
LWy239	
SynII	1.3	 212908	 212941	 INS	
pWL046	 15345	 2067	 INS_fragment	
SynII	1.3	 121692	 134777	 INV	
SynII	1.3	 297748	 317917	 DUP	
SynII	1.3	 297748	 298280	 DUP	
SynII	1.3	 307359	 317917	 DUP	
SynII	1.3	 690041	 716070	 DUP	
SynII	1.3	 403656	 439168	 INV	
SynII	1.3	 581558	 624877	 INV	
SynII	1.3	 686278	 690074	 DEL	
SynII	1.3	 732447	 732697	 DEL	
LWy260	
(LWy239+)	
SynII	1.3	 212908	 212941	 INS	
pWL046	 15345	 2067	 INS_fragment	
SynII	1.3	 121692	 134777	 INV	
SynII	1.3	 297748	 317917	 DUP	
SynII	1.3	 297748	 298280	 DUP	
SynII	1.3	 307359	 317917	 DUP	
SynII	1.3	 690041	 716070	 DUP	
SynII	1.3	 403656	 439168	 INV	
SynII	1.3	 581558	 624877	 INV	
	 -	150	-	
SynII	1.3	 686278	 690074	 DEL	
SynII	1.3	 732447	 732697	 DEL	
SynII	1.3	 322015	 395694	 DUP	
SynII	1.3	 322015	 398763	 INV	
SynII	1.3	 398730	 555721	 DEL	
LWy261	
(LWy239-)	
SynII	1.3	 212908	 212941	 INS	
pWL046	 15345	 2067	 INS_fragment	
SynII	1.3	 121692	 134777	 INV	
SynII	1.3	 297748	 317917	 DUP	
SynII	1.3	 297748	 298280	 DUP	
SynII	1.3	 307359	 317917	 DUP	
SynII	1.3	 690041	 716070	 DUP	
SynII	1.3	 403656	 439168	 INV	
SynII	1.3	 581558	 624877	 INV	
SynII	1.3	 686278	 690074	 DEL	
SynII	1.3	 581790	 628076	 INV	
SynII	1.3	 732447	 732697	 DEL	
*	 INS:	 insertion;	 INV:	 inversion;	 DEL:	 deletion;	 DUP:	 duplication;	 Tandem_DUP:	
tandem	duplication.	










demonstration	 pathways,	 b-carotene	 and	 violacein,	 were	 SCRaMbLEed	 into	 the	
	 -	151	-	
synthetic	chromosome	 II	and	selected	 for	 further	verification.	The	 integration	and	
other	 genome	 variations	were	 confirmed	 by	 next-generation	 sequencing	 and	 the	
phenotypes	 were	 characterized	 by	 chemical	 analysis.	 The	 result	 proves	 that	
SCRaMbLE-in	can	diversify	chemical	production	by	integration	to	different	genomic	
locations.	 The	 violacein	 pathway	 SCRaMbLEed-in	 strains	 were	 SCRaMbLEed	
continuously	 for	 further	 chassis	 diversification,	 after	 which	 both	 up-	 and	 down-	
regulated	strains	were	generated	with	the	highest	violacein	production	of	16.8mg/L,	
almost	 17-fold	 of	 the	 HO	 integrated	 control	 strain.	 	 A	 gene	 complementation	
experiment	was	carried	out	to	study	the	down-regulated	strains.		
Besides	 the	 characterization	 of	 SCRaMbLE-in,	 automated	 methods	 for	 screening	
strains	with	higher	production	after	SCRaMbLE	have	also	been	tried.	However,	there	
are	 still	 some	 difficulties	 that	 have	 not	 been	 solved.	 First,	 some	 non-loxP	 guided	














Therefore,	 it	will	 be	worth	 trying	 the	 SCRaMbLE-in	method	on	different	 synthetic	
strains	or	combined	synthetic	strains	in	future	for	function	evaluation.	It	is	probable	
that	 the	production	of	 violacein	or	 other	pathways	 can	be	 further	 improved	with	
more	genome	variation	possibilities.		
	 -	152	-	
Though	 the	 main	 purpose	 of	 SCRaMbLE-in	 is	 to	 screen	 out	 strains	 with	 higher	
production,	it	is	worth	understanding	the	genotype	and	phenotype	relationship	after	
SCRaMbLE.	The	difficulty	is	that	with	so	many	and	sometimes	complicated	genome	
variations,	 a	 huge	 amount	 of	work	will	 be	 needed	 using	 traditional	 experimental	
methods.	Therefore,	systems	biology	and	computational	biology	methods	should	be	
developed	to	facilitate	the	interpretation	of	genome	rearrangements	especially	when	
SCRaMbLE	 or	 SCRaMbLE-in	 will	 be	 applied	 to	 the	 final	 synthetic	 yeast	 with	 joint	









the	pathway	 level	will	 be	 introduced.	Pathway	 level	optimization	mainly	 refers	 to	
expression	level	optimization	of	catalytic	enzymes	in	the	pathway.	One	popular	way	
of	 diversifying	 expression	 level	 of	 genes	 in	 a	 pathway	of	 interest	 is	 combinatorial	
assembly	of	transcriptional	regulation	elements	like	promoters,	RBS	and	terminators	
with	the	ORFs	of	pathway	genes	(Awan	et	al.,	2017;	Y.	Guo	et	al.,	2015;	Lee	et	al.,	
2013;	 Mitchell	 et	 al.,	 2015).	 The	 combinatorial	 assembly	 method	 requires	 large	
library	 construction	 of	 DNA	 circuits.	 This	 is	 used	 for	 small	 pathways	with	 several	
genes	 but	 for	 large	 pathways	 with	 tens	 of	 genes,	 the	 coverage	 of	 possible	
combinations	 can	 be	 compromised.	 Meanwhile,	 the	 construction	 of	 pathways	
normally	 includes	several	rounds	of	hierarchical	assembly,	which	can	be	time-	and	
reagent-	 consuming	 especially	 for	 large	 pathways.	 Here,	 a	 recombinase-based	
integration	method	was	designed	for	direct	integration	of	transcriptional	regulation	
elements	to	target	genes	in	a	pathway	of	interest.	The	advantage	of	the	method	is	
that	 it	can	rapidly	 integrate	a	 library	of	elements	of	 interest	to	any	DNA	fragment	
with	corresponding	recombination	sites	and	avoid	repeated	DNA	circuit	construction.	
The	 recombinase	 can	 be	 simply	 mixed	 with	 DNA	 and	 function	 directly	 in	
microcentrifuge	tubes.	Based	on	previous	work	on	recombinase	in	vitro	function	and	
the	recent	discovery	of	new	recombinases,	Cre,	Dre	and	VCre	were	chosen	to	explore	
the	 feasibility	 of	 this	 application.	 The	 violacein	 synthetic	 pathway	 and	b-carotene	
synthetic	pathway	were	used	for	demonstrating	the	functionality	of	the	recombinase	
toolkit	 in	 vitro.	 A	 library	 of	 characterized	 yeast	 promoters	 was	 chosen	 as	 the	
transcriptional	 regulatory	 elements	 for	 integration	 to	 regulate	 key	 genes	 in	 the	














and	 Dre/rox	 systems	 were	 explored	 for	 in	 vitro	 DNA	 element	 integration.	 The	
recombinases	can	be	mixed	directly	with	DNA	and	function	in	vitro.	The	elements	of	
interest	 in	 this	 study	 are	 from	 a	 YeastFab	 promoter	 library	 with	 their	 strength	
characterized.	The	integration	targets	can	be	upstream	of	any	gene	of	any	pathway	
















































































pET-28a	 (Novagen)	 to	 be	 expressed	 in-frame	 with	 a	 C-terminal	 His6	 tag.	 All	
recombinase	sequences	were	flanked	by	NcoI	and	XhoI	restriction	sites	with	start	and	
stop	 codons	 removed	 and	 a	 2bp	 “gc”	was	 added	 after	 the	NcoI	 site	 for	 in-frame	




PCR	 from	 a	 CreEBD	 expression	 vector	 (Lindstrom	 &	 Gottschling,	 2009);	 Dre	 was	

































purification	 was	 from	 the	 in	 vivo	 Dre	 expression	 device	 and	 was	 yeast	 codon-	
optimized.		
Therefore,	 for	 a	 second	 round	 of	 expression	 and	 purification	 of	 the	 remaining	
recombinases,	all	sequences	were	either	from	the	original	phage	source	strain	(for	








and	purification	of	Cre	and	Dre.	 For	Cre,	 I-P	 samples	have	more	 intense	bands	at	
around	39KDa	than	T0,	while	for	Dre	there	is	not	much	difference	between	I-P	and	
T0.	The	 intensity	of	protein	 I-S	 is	weak	and	 further	modification	of	 the	 sonication	
procedure	 is	 needed.	After	 protein	 purification,	 SDS-PAGE	 shows	 that	 Cre	 gives	 a	
protein	band	of	the	right	size	while	there	is	no	band	for	Dre.	b.	Expression	test	and	





for	 SCre.	 M:	 Marker,	 protein	 ladder;	 T0:	 Time	 zero	 without	 IPTG	 induction.	 I-P:	

















and	 solvent	 optimization	 could	 be	 continued	 for	 future	 purification.	 However,	
because	the	purpose	of	the	study	is	to	select	candidates	for	in	vitro	recombination	















After	 the	 recombinases	 were	 extracted	 and	 purified,	 the	 next	 step	 was	 to	 test	
whether	they	had	recombination	function	in	vitro.	Two	strategies	were	used	for	the	
function	 characterization.	 The	 first	 step	 is	 to	 qualitatively	 evaluate	 whether	




digestion	 map	 comparison	 before	 and	 after	 in	 vitro	 recombination	 was	 used	 to	







color	 of	 the	 colony	 reports	 the	 recombination	 event.	 The	 excision	 rate	 can	 be	




cassette	 and	 an	 RFP	 cassette	 with	 two	 flanking	 recombination	 sites	 but	 with	 an	














bands	 of	 1.2Kb	 and	 5Kb.	 b.	 Red/White	 color	 reporter	 devices	 for	 recombination	









Three	 reporter	 plasmids,	 pRS413-loxPURA3loxP,	 pRS413-roxURA3rox	 and	 pRS413-
VloxPURA3VloxP,	were	used	for	the	test.	The	purified	Cre,	Dre	and	VCre	were	mixed	






5.6).	 The	 digestion	 patterns	 of	 the	 rest	 are	 all	 the	 same	 as	 the	 negative	 control,	
meaning	 that	 the	 functions	 of	 the	 three	 recombinases	 are	 orthogonal.	 The	
	 -	163	-	





reporter	 plasmids,	 pRS413-loxPURA3loxP,	 pRS413-roxURA3rox	 and	 pRS413-
VloxPURA3VloxP	were	mixed	with	Cre,	Dre	and	VCre	for	recombination	reaction.	The	













Dre/rox	 is	 around	 0.55%	 and	 for	 VCre/Vlox	 is	 around	 0.3%	 (Figure	 5.7b).	 The	








Excision	 rate	 quantification.	 Cre/loxP	 has	 the	 highest	 excision	 rate	 of	 43.5%;	
VCre/Vlox	has	an	excision	rate	of	29.7%;	Dre/rox	has	an	excision	rate	of	26.2%.	b.	
Integration	rate	quantification.	The	integration	rate	of	Cre/LoxP	is	around	0.55%;	that	










vitro	 to	 improve	 the	 integration	efficiency	of	 “Elements	of	 Interest“	 (EoI).	 Two	 LE	
mutants	were	put	outside	of	the	EoI	and	one	RE	mutant	was	put	 in	acceptor	DNA	
(Figure	5.8a).	The	integration	between	LE	and	RE	sites	will	result	in	a	LE-RE	double	




sites,	 lox71,	 lox66,	 loxJT15,	 loxJT510	 and	 loxJTZ17,	were	 reported	 to	 increase	 the	
integration	 rate	 in	 ES	 cells	 and	 E.	 coli	 (K.	 Araki,	 Araki,	 &	 Yamamura,	 1997;	 J.	 G.	
Thomson,	E.	B.	Rucker,	3rd,	&	J.	A.	Piedrahita,	2003a).	In	this	study,	we	compared	and	
	 -	165	-	
quantified	 the	 excision	 efficiency	 of	 these	mutants	 using	 our	 quantitative	 in	 vitro	
recombination	 assay.	 The	 LE	mutants	 include	 lox71,	 loxJT15	 and	 loxJT510	 and	RE	
mutants	 include	 lox66	 and	 loxJTZ17	 (Figure	 5.8b).	 The	 mutation	 bases	 on	 the	
palindromic	 arms	 of	 lox71	 and	 lox66	 are	 symmetrical,	 while	 the	 other	 three	 are	
independent	mutants.	 Therefore,	we	 also	 created	 the	 RE	mutants	 of	 loxJT15	 and	
loxJT510	and	 the	LE	of	 loxJTZ17.	 	The	 in	vitro	 excision	assay	was	carried	out	both	
between	identical	LoxP	mutant	sites	and	between	the	LoxP	WT	site	and	LE_RE	joint	
sites.	 A	 higher	 excision	 rate	 between	 identical	 loxP	 mutant	 sites	 and	 lower	 rate	
between	WT	and	joint	mutant	site	is	necessary	for	better	integration.	In	addition	to	
the	 palindromic	 mutants,	 spacer	 mutants	 were	 also	 explored	 for	 orthogonal	















out	both	between	 identical	 LoxP	mutant	 sites	and	between	 the	LoxP	WT	site	and	
LE_RE	joint	site	pairs.	A	higher	excision	rate	between	identical	loxP	mutant	sites	and	








After	 further	 tests	of	 integration	 rate,	we	 found	 that	 the	 integration	 capability	of	
loxJTZ17	to	loxJT15	was	the	best,	around	3-fold	that	of	the	loxP	WT	site	(Figure	5.9b).		
Based	on	 the	 integration	assay	of	 the	engineered	Cre/LoxP	 system,	we	 chose	 the	
loxJT15	and	loxJTZ17	pair	as	the	best	candidate	for	EoI	integration.		
a b 	












spacer	 mutants	 to	 generate	 more	 orthogonal	 sites.	 The	 spacer	 region	 of	 the	
recombination	site	determines	the	homology	recognition	during	the	recombination.	
Two	loxP	spacer	mutants,	m3	and	m7,	were	reported	to	be	orthogonal	with	loxP	WT	








integration	 rate	 of	 spacer	 and	 palindromic	 hybrid	 sites.	 The	 excision	 rates	 of	






After	 the	 excision	 rate	 measurement	 of	 the	 spacer	 mutants,	 it	 was	 decided	 to	
combine	the	spacer	mutations	and	palindromic	arm	mutations	to	see	whether	the	
integration	 rate	 could	 be	 improved	 for	 these	 hybrid	 sites.	 However,	 the	
quantification	 result	 shows	 that	 the	 excision	 rates	 of	 the	 hybrid	 sites	were	much	
lower	 than	 loxP	WT	 sites,	 ranging	 from	 1%	 to	 8%	 (Figure	 5.10b).	 The	 integration	
between	loxJT15m3	and	loxJTZ17m3	or	loxJT15m7	and	loxJTZ17m7	hardly	happened	
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(Figure	5.10b),	which	 is	disappointing	 for	 further	application	of	 these	sites.	 It	also	
indicates	that	our	understanding	of	the	recombination	sites	and	function	modulation	




The	 choice	 of	 the	 EoI	 is	 very	 broad:	 it	 can	 be	 almost	 any	 DNA	 sequence.	 To	





promoters	 from	the	 library	as	a	 first	 step	and	will	be	used	 for	 later	 integration	 to	
target	genes	of	interest.	In	the	Design	of	the	EoI	loader,	a	BsmBI-flanked	RFP	cassette	
was	included	for	compatible	Golden	Gate	assembly	with	the	promoter	library	(Figure	
5.11a).	A	URA3	expression	unit	was	assembled	 in	 series	with	 the	RFP	cassette	 for	
integration	 selection.	 The	 URA3-RFP	 cassette	 was	 further	 flanked	 with	 the	






cassette	 for	 integration	 selection	 and	 two	 recombination	 sites	 for	 the	 two-step	








these	 characterized	 promoters,	 25	 were	 chosen	 with	 three	 different	 ranges	 of	
strength,	 including	 “>10”,	 “2-10”,	 and	 “<2”	 to	 test	 their	 ability	 to	 diversify	 gene	







































the	 RFP	 cassette	was	 surrounded	 by	 either	 two	 loxP,	 two	 rox	 or	 two	 VloxP	 sites	
respectively.	 These	 recombination	 site	 flanking	 RFP	 cassettes	 were	 put	 into	 the	
YeastFab	HCKan_P	vector	as	the	promoter	libraries	for	Golden	Gate	construction	of	
the	pathway.	Taking	b-carotene	pathway	construction	as	an	example,	three	rounds	
of	 Golden	 Gate	 assembly	 were	 included.	 	 In	 step	 1,	 all	 site-RFP	 cassettes	 and	
promoters	were	assembled	to	HCKan_P	vector,	the	coding	genes	were	assembled	to	
HCKan_O	 vector	 and	 the	 terminators	were	 assembled	 to	HCKan_T	 vector	 by	 BsaI	












Step1:	 recombination	 sites	 flanking	RFP	and	constitutive	promoters	were	put	 into	
HCKan_P	receptor	vector;	CrtI,	CrtE,	CrtYB,	VioA-E	coding	sequences	were	put	into	
HCKan_O	 receptor	 vector;	 terminators	 were	 put	 into	 HCKan_T	 vector.	 Step2:	
RFP/promoter	 element,	 CDS	 and	 terminator	 were	 assembled	 into	 POT	 unit	 in	
different	vectors	by	BsmBI	Golden	Gate	assembly.	Step3:	the	unit	with	recombination	
site	flanking	RFP	went	through	one	round	of	in	vitro	excision	by	recombinase;	unit	

















in	 vitro	 application	workflow	of	 recombinases	on	pathway	diversification	 includes	






did	 an	 assay	 to	 evaluate	 the	 potential	 effect	 of	 the	 recombination	 site	 on	 gene	
expression.	 Considering	 the	 palindromic	 structure	 of	 the	 recombination	 site,	 a	
hairpin	could	form	with	the	opening	of	double-strand	DNA,	and	affect	transcription	






Figure	 5.14|	 Effect	 of	 recombination	 sites	 on	 gene	 expression.	 LoxP,	 VloxP,	 and	
loxJT15-JTZ17	 were	 inserted	 between	 promoters	 and	 the	 eGFP	 gene.	 Since	 the	
overhang	 of	 BsmBI	 contains	 the	 ATG	 start	 codon	 and	 the	 site	 is	 34bp,	 the	 2bp	
sequence	“TG”	was	inserted	after	the	recombination	site	for	in-frame	expression	of	
GFP.	Strong	promoter	PTDH3,	medium	promoter	PACT1	and	a	weak	promoter	PYGR270W	
were	used	 to	compare	 the	similarity	of	 recombination	site	effects	under	different	
promoters.	It	was	found	that	recombination	sites	indeed	have	a	negative	effect	on	
GFP	expression	and	the	effects	are	similar	with	different	promoters.	Double	mutant	




We	 tested	 the	 effect	 of	 the	 recombination	 site	 by	 putting	 the	 selected	 three	
recombination	sites,	 loxP,	 loxJT15-JTZ17	and	Vlox,	between	the	promoter	and	 the	




sites,	 loxP	 has	 an	 obvious	 negative	 effect	 on	 gene	 expression;	 Vlox	 has	 lighter	
negative	effect	 than	 the	 loxP	 site;	 the	double	mutant	 site	 loxJT15-JTZ17	has	 least	
effect	on	gene	expression.	This	could	be	explained	by	the	asymmetric	structure	of	
the	 double	mutant	 site.	 	 Therefore,	 the	 LE/RE	 strategy	 can	 not	 only	 improve	 the	









directly	 transformed	 into	 yeast	 and	 screened	on	 SC-His-Ura	 plates	 (Figure	 5.15b).	
After	 plate	 selection,	 the	 plasmids	 were	 recovered	 from	 clones	 for	 sequencing	












Based	 on	 the	 characterization	 results,	 Cre/loxJT15-JTZ17	 and	 VCre/Vlox	 were	
selected	 for	 pathway	 diversification	 with	 the	 YeastFab	 promoter	 library.	 Two	
benchmark	pathways,	b-carotene	and	violacein,	were	used	for	demonstration.	After	
promoter	 loading,	 in	 vitro	 recombination	 and	 yeast	 transformation,	 strains	 with	
different	 pathway	 circuits	were	 selected	 on	 SC-His-Ura.	 As	we	 can	 see	 for	 the	b-
carotene	pathway,	this	in	vitro	promoter	integration	generated	yeast	colonies	with	a	
range	of	different	colors	and	colony	sizes,	 indicating	diversified	yields	or	chemical	








Strain	ID	 Strain	 Description	 Genotype	
LWy068	 By4741	 PYPT1	Promoter	integration	VloxCrtI		 leu2∆0	met15∆0	LYS2		
LWy069	 By4741	 PRPL22B	Promoter	integration	VloxCrtI		 leu2∆0	met15∆0	LYS2		
LWy070	 By4741	 PSTE2	Promoter	integration	VloxCrtI		 leu2∆0	met15∆0	LYS2	
LWy071	 By4741	 PHXK1	Promoter	integration	VloxCrtI		 leu2∆0	met15∆0	LYS2	
LWy072	 By4741	 PACT1	Promoter	integration	VloxCrtI		 leu2∆0	met15∆0	LYS2	
LWy073	 By4741	 PHSP12	Promoter	integration	VloxCrtI		 leu2∆0	met15∆0	LYS2	
LWy076	 By4741	 PTDH3	Promoter	integration	VloxCrtI		 leu2∆0	met15∆0	LYS2	
LWy087	 By4741	 PSCW4	Promoter	integration	VloxVioA		 leu2∆0	met15∆0	LYS2	
LWy091	 By4741	 PRPL27	Promoter	integration	lox1517VioA		 leu2∆0	met15∆0	LYS2	
LWy092	 By4741	 PAGA2	Promoter	integration	lox1517VioA		 leu2∆0	met15∆0	LYS2	
LWy093	 By4741	 PHXK1	Promoter	integration	lox1517VioA		 leu2∆0	met15∆0	LYS2	
LWy094	 BY4741	 PPNC1	Promoter	integration	lox1517VioA		 leu2∆0	met15∆0	LYS2	
	
For	 the	 b-carotene	 pathway,	 the	 production	 of	 lycopene	 and	 b-carotene	 were	
quantified	by	LCMS.	The	results	and	activity	of	the	integrated	promoters	are	listed	in	
Figure	5.16b.	The	result	shows	that	CrtI	integrated	with	the	strongest	promoter	PTDH3	
has	 the	 highest	 carotenoid	 production.	 For	 the	 other	 variants,	 the	 carotenoid	
production	is	not	in	proportion	with	the	activity	of	the	promoters;	for	example	the	
PACT1-integrated	strain	has	similar	yield	with	PTDH3-integrated	strain,	while	the	PRPL22B-
integrated	 strain	 has	 the	 lowest	 	b-carotene	 	 yield	 even	 though	PRPL22B	 is	 not	 the	
weakest	promoter.	 In	addition,	since	the	function	of	CrtI	was	reported	to	catalyze	
transformation	 of	 phytoene	 to	 lycopene,	 theoretically	 the	 ratio	 of	 b-carotene	 to	









quite	 different,	 while	 the	 fitness	 for	 the	 two	 strains	 are	 similar.	 Such	 fitness	
difference	 could	 be	 the	 result	 of	 metabolic	 burden	 from	 the	 accumulated	








Figure	 5.16|Pathway	 diversification	 and	 phenotype-genotype	 analysis.	 a.	
Transformation	results	of	the	in	vitro	integration	reactions	of	promoters	into	the	b-
carotene	 acceptor	 pathway.	 b.	 Carotenoids	 production	 and	 promoter	 activity	
comparison	 between	 the	 strains	 with	 CrtI	 gene	 targeted	 b-carotene	 pathway.	 c.	
Fitness	comparison	between	the	strains	with	CrtI	gene	targeted	b-carotene	pathway.	
d.	Violacein	production	and	promoter	activity	comparison	between	strains	with	VioA	





integrated	promoters,	 the	degree	of	 correlation	 is	 higher	 than	 that	of	b-carotene	
pathway	 with	 only	 one	 exception,	 the	 strain	 with	 medium	 promoter	 PPNC1	 has	 a	
higher	production	(Figure	5.16d).	The	fitness	of	the	promoter	integrated	strains	of	
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described.	 Three	 out	 of	 five	 recombinase	 candidates,	 Cre,	 Dre	 and	 VCre	 were	
successfully	extracted	and	purified.	The	excision	rate	and	integration	rate	of	the	three	
natural	systems	were	quantified	by	the	red/white	color	ratio	strategy.	To	 improve	




and	 VCre/Vlox	 systems,	 the	b-carotene	 and	 violacein	 pathways	were	 successfully	
diversified.	The	results	prove	that	the	 idea	of	element	 integration	by	recombinase	
activity	 in	 vitro	 and	 its	 application	 to	metabolic	 engineering	 is	 feasible.	 There	 are	
some	 limits	of	 the	methods.	Since	 the	 integration	rate	 is	 still	 fairly	 low	even	after	






that	 can	 be	 optimized	 or	 attempted.	 One	 is	 to	 further	 investigate	 the	 working	
conditions	 of	 the	 recombination	 system	 in	 vitro,	 for	 example	 improving	 on	 the	
protein	storage	buffer	and	recombination	reaction	buffer.	The	other	is	to	replace	the	















three-partner	 consortium	 to	 produce	 and	 screen	 for	 new	 antimicrobials	 active	
against	tuberculosis.		
6.1.1	Workflow	of	pathway	diversification	screening	
Antibiotics	 can	 be	 biologically	 derived	 chemicals	 from	microbes	 and	 plants	 or	 be	
chemically	designed	and	synthesized.	Naturally	synthesized	chemicals	are	the	main	








pathways	 (NRPSs),	 ribosomally	 synthesized	 and	 post-translationally	 modified	









Figure	 6.1|	 Workflow	 of	 SynNP	 pathway	 construction,	 diversification	 and	
characterization.	a.	Genetic	library	collection	for	SynNP	pathways	by	genome	mining	
and	 literature	 search.	 b.	 Diversification	 and	 optimization	 of	 SynNP	 pathways	 by	
combinatorial	assembly	of	tailoring	enzymes	or	regulatory	elements.	c.	Screening	and	






large	 genes,	 different	 assembly	 strategies	 and	 hierarchical	 assembly	methods	 are	
needed	 for	 pathway	 construction.	 For	 pathway	 diversification,	 two	 combinatorial	
assembly	strategies	were	designed:	combinatorial	assembly	of	tailoring	enzymes	and	
combinatorial	assembly	of	regulatory	elements.	The	precursor	molecules	first	need	
to	 be	 processed	 by	 multi-domain	 synthetases	 to	 synthesize	 the	 basic	 chemical	





tailoring	 enzymes	 such	 as	 group-transferases,	 halogenases,	 P450,	 etc.	 The	 initial	
heterologous	expression	level	of	each	gene	might	not	be	favorable	for	the	metabolic	
flux	balance,	therefore	expression	level	optimization	is	very	 likely	needed	for	 later	




antibiotic	 activity.	 	 Both	 traditional	 cell-based	 screening	 and	 artificial	 biosensor-
based	screening	can	be	used	for	detecting	product	formation	(Figure	6.1c).	For	cell-
based	assay,	ideally	Mycobacterium	tuberculosis	should	be	the	test	strain.	However,	
because	M.	 tuberculosis	 is	 of	 biosafety	 level-BSL3	 and	 only	 one	 partner	 from	 the	
consortium	 has	 this	 capability,	 not	 all	 assays	 can	 be	 done	 with	M.	 tuberculosis.	
Substitute	BSL-1	 species	 like	Bacillus	 subtilis	 and	Mycobacterium	 smegmatis	were	
therefore	used	for	initial	antibiotic	function	testing	since	they	are	all	gram-positive	
bacteria.	For	the	biosensor-based	assay,	the	sensor	can	be	either	specific	compound-
responsive	 reporters	 like	 riboswitches	 in	 yeast	 or	 in	 vitro,	 or	 be	 stress	 sensing	












diffusion	 assay	were	 applied	 (Figure	 6.2).	 In	 the	 overlay	 assay,	 yeast	 cells	 with	 a	


















the	 promoters,	 BSGs	 and	 terminators	 were	 PCR-amplified	 and	 respectively	
assembled	 to	 HCKan_P,	 HCKan_O	 and	 HCKan_T	 vectors	 using	 BsaI;	 in	 step	 2,	
transcription	 units	 (TUs)	 were	 constructed	 by	 assembling	 promoter,	 BSG	 and	
terminator	in	a	specific	POT	vector	with	BsmBI	Golden	Gate	assembly;	in	step	3,	up	



























vectors	 are	 centromeric	 plasmids.	 The	 combinatorial	 assembly	 of	 regulatory	
elements	can	be	carried	out	at	step	two.		One	more	advantage	of	the	multi-TU	cluster	









and	 HCKan_T	 vectors	 respectively.	 Step	 2:	 Promoter,	 BSG	 and	 terminator	 are	




for	 yeast	 in	 vivo	 assembly.	Step	4:	For	pathways	with	up	 to	30	BSGs,	 five	pYFASS	
vectors	can	be	used	to	accommodate	multi-TU	clusters	and	the	clusters	are	finally	
assembled	 to	 a	 YAC	 vector	 by	 in	 vivo	 yeast	 assembly.	 The	 YAC	 vector	 should	 be	






































The	 glycosylated	 thiopeptide	 nocathiacin	 I	 was	 identified	 from	 the	 Nocardia	 sp.	





like	 the	 NosM	 gene,	 encodes	 the	 precursor	 peptide	 for	 the	 pathway.	 Since	 the	
expression	level	of	NocM	determines	the	quantity	of	substrate	for	the	pathway,	it	is	
better	 to	 get	 it	 highly	 expressed	 to	 achieve	 a	 higher	 production	 of	 the	 final	
nocathiacin	 I.	 Therefore,	 the	 strongest	 promoter,	 PTDH3,	 was	 used	 to	 drive	 the	







of	 these	 tailoring	 enzymes.	 Except	 for	 the	NocM	TU,	 the	 rest	 of	 the	 TUs	 all	 have	








Figure	 6.4|Assembly	 and	 expression	 characterization	 strategy	 for	 the	 RiPPs	





TU	 were	 allocated	 to	 different	 pYFASS	 vectors	 and	 all	 sugar	 modification	 genes	
NocS1-6	were	all	 assembled	 to	pYFASS2.	b.	Expression	 characterization	 circuit	 for	
BSGs.	All	BSGs	were	tagged	with	FLAG	for	western	blot	expression	test.	All	the	tagged	













































































The	 pYFASS	 vectors	 were	 based	 on	 the	 HCKan_T	 vectors	 and	 the	 construction	
includes	one	round	of	Golden	Gate	assembly	and	one	round	of	Gibson	assembly.	In	
the	first	step,	the	100bp	yeast	assembly	arms	were	standardized	with	BsaI	overhangs	
and	assembled	 into	HCKan_T	by	Golden	Gate	assembly	with	EcoIV	 restriction	 site	
between	the	two	arms.	In	the	second	step,	the	ccdB	cassette	was	amplified	and	tailed	
with	the	ACCT-TGAG	YeastFab-compatible	BsaI	overhangs	by	PCR,	and	was	inserted	
to	 the	 EcoIV	 site	 by	 Gibson	 assembly.	 The	 reaction	 was	 transformed	 into	 ccdB	
Survival™	 2	 strain	 for	 ccdB	 gene	 cloning.	 The	 ccdB	 counter-selection	marker,	 the	
YeastFab-compatible	BsaI	sites	and	the	homologous	arms	for	yeast	in	vivo	assembly	
were	put	together	as	designed,	and	since	the	HCKan_T	vector	naturally	contains	a	
pair	of	BsmBI	 sites	 flanking	 the	arms,	 the	construction	of	 the	pYFASS	vectors	was	
complete.	
6.2.2	Construction	of	the	nocathiacin	I	pathway	
PCR	 amplification	 of	 all	 BSGs	 was	 successful	 (Figure	 6.5a).	 After	 assembly	 with	
HCKan_O	vector,	two	colonies	from	each	of	the	genes	were	picked	for	colony	PCR	
screening.	The	result	shows	that	at	least	one	of	each	has	the	right	size	(Figure	6.5b).	
The	HCKan_BSGs	were	 sent	 for	 sequencing	 confirmation	 before	 POT	 assembly	 to	
avoid	introduction	of	any	mutation	in	the	PCR	process.	Once	the	HCKan_BSGs	passed	





the	 correct	 digestion	 pattern.	 After	 trouble-shooting,	 it	 was	 found	 that	 this	 was	
because	 not	 all	 BsaI	 and	 BsmBI	 sites	 were	 removed	 from	 the	 promoters	 and	
terminators	 to	avoid	affecting	the	 function	of	 the	elements,	but	 they	reduced	the	
efficiency	of	the	Golden	Gate	assembly.	Then	those	with	either	BsaI	or	BsmBI	sites	
were	 substituted	 with	 other	 promoters	 from	 the	 YeastFab	 library	 to	 avoid	 such	
problems.	When	the	correctness	of	each	POT-TU	assembly	was	confirmed,	they	went	














Figure	 6.5|Screening	 and	 quality	 control	 of	 nocathiacin	 I	 construction.	 a.	 BSG	
amplification	by	PCR.	The	sizes	of	the	bands	are	listed	in	figure	6.4a.		b.	Colony	PCR	
screening	of	first	step	BSG	assembly	with	HCKan_O	vector.	The	sizes	of	the	bands	are	


















For	the	nocathiacin	 I	pathway,	 there	are	six	 junctions	and	each	 junction	 is	around	
400bp	 (Figure	6.6a).	Eight	colonies	were	picked	and	tested	with	 the	 junction	PCR.	

















upstream	 and	 downstream	 of	 the	 seam	 between	 the	 clusters	 and	 the	 PCR	
amplification	products	are	all	around	400bp	for	the	six	junctions.	Two	out	eight	clones	
have	 complete	 junction	 PCR	 signals.	 b.BSG	 colony	 PCR	 as	 a	 further	 test	 of	 the	






























(Figure	6.8).	 The	 strains	were	also	 sent	 to	our	 collaborator,	 the	Wright	group,	 for	















overlay	 assay	was	 performed	 on	 both	 single	 colonies	 and	 spotted	 yeast	with	 the	

















the	promoter	 is	not	 context-independent	and	 somehow	 the	 sequence	of	 the	BSG	
makes	a	difference	to	transcription	efficiency.	This	is	not	a	big	problem	since	it	can	








with	 negative	 signals	 were	 NocS1	 and	 NocI	 that	 driven	 by	 YHR214W_P	 and	
YHR128W_P	respectively	since	they	only	have	shorter	bands	which	are	more	likely	to	




As	 is	 mentioned	 in	 the	 design	 section,	 all	 BSGs	 were	 fused	 with	 the	 FLAG	 tag	










negative	 western	 blot	 signal	 of	 the	 three	 genes.	 Potential	 explanations	 include	
technical	problems	of	western	blot	for	NocM	considering	its	small	peptide	size,	the	
codons	 for	 these	 three	genes	may	need	to	be	 further	optimized	 to	enable	proper	
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translation,	 or	 the	 stability	 of	 these	 proteins	 may	 be	 low	 in	 S.	 cerevisiae,	 etc.	 A	
potential	solution	for	translational	difficulty	is	to	repeat	codon	optimization	for	these	
genes	using	some	other	software	such	as	the	“GeneDesign”	used	for	recombinase	
codon	 optimization;	 for	 solving	 protein	 stability	 problems,	 on	 one	 hand	 the	
expression	 of	 the	 three	 genes	 can	 be	 tuned	 to	 avoid	 instability	 caused	 by	
overexpression,	while	on	 the	other	hand	 the	“N	end	 rules”	 for	estimating	protein	




























































Figure	 6.11|b-carotene	 production	 diversification	 by	 combinatorial	 assembly.	 A	
mixture	of	2	strong,	2	medium	and	1	weak	promoters	and	a	mixture	of	5	terminators	
were	used	for	the	combinatorial	assembly	with	CrtI,	CrtE	and	CrtYB	gene	from	the	b-
carotene	pathway.	The	 transformation	 result	 shows	 that	 there	are	different	yeast	






orange,	 which	 indicates	 the	 potential	 for	 diversifying	 and	 optimizing	 the	 SynNP	




In	 this	 chapter,	 the	main	 strategies	of	 applying	 the	 synthetic	biology	platform	 for	
engineering	natural	products	pathways	in	yeast	was	described.	For	a	pilot	application,	
the	 platform	 was	 specifically	 designed	 for	 screening	 new	 antibiotics	 against	
tuberculosis.	 The	 project	 is	 a	 collaboration	 between	 three	 groups	 and	 my	
contribution	to	the	project	includes	setting	up	the	workflow	for	pathway	construction	
from	our	 side,	which	 enables	 compatibility	 between	 combinatorial	 assembly	with	
YeastFab	Golden	Gate	 standards	 and	 the	 YAC	 yeast	 in	 vivo	 assembly	 standards.	 I	
designed	and	constructed	a	set	of	pYFASS	vectors	and	demonstrated	the	workflow	
and	 assembly	 thoroughly	with	 the	 50kb	 nocathiacin	 I	 pathway	which	 contains	 26	
BSGs.	In	addition	to	the	DNA	assembly	method,	I	contributed	a	positive	control	for	
the	 cell-based	 overlay	 assay	 with	 the	 violacein-producing	 yeast.	 Expression	
characterizations	 for	 the	 RiPPs	 exemplar	 pathway	 nocathiacin	 I,	 including	 overlay	
assay,	RT-PCR	and	western	blot,	were	performed.		
Though	 the	 assembled	 nocathiacin	 I	 pathway	 was	 not	 functional	 in	 yeast,	
troubleshooting	has	narrowed	down	problems	 to	 the	expression	of	 the	precursor	
peptide	NocM	and	 two	other	 genes	 involved	 in	 core	 chemical	 scaffold	 formation.	
Future	work	should	be	done	to	fix	the	expression	problems	of	NocM,	NocN	and	NocO	








combinatorial	 assembly	 of	 the	 enzymes.	 Constructing	 and	 screening	 effective	
pathways	 from	 the	 library	with	 so	many	pathway	 classes	 and	huge	 combinatorial	
possibilities	is	also	incredibly	challenging,	therefore	it	is	necessary	to	establish	a	fully	
automated	 assembly	 platform	 for	 high-throughput	 pathway	 construction	 and	


















recombinases.	 To	 serve	 the	 purpose	 of	 controllable	 co-SCRaMbLE	 of	 the	 normal	
synthetic	chromosomes	and	the	tRNA	Neochromosome	for	the	Sc	2.0	consortium,	
two	 orthogonal	 recombination	 activation	 systems,	 CrePBD	 and	 DreEBD,	 were	
constructed	and	characterized	in	S.	cerevisiae.	Primary	SCRaMbLE	assays	by	Cre	have	
been	performed	on	SynII,	SynIXR,	SynV	and	some	other	synthetic	chromosomes	like	





















the	 host.	 The	 SynII	 strain	 and	 two	 pigment	 synthesis	 pathways,	 violacein	 and	 b-
carotene,	were	used	for	demonstration.	With	in	vivo	evolution	by	SCRaMbLE-in	and	
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provide	 a	 universal	 platform	 and	method	 for	 metabolic	 engineering.	 Besides	 the	
demonstration	pathways,	its	application	can	be	expanded	to	any	pathway	for	stable	
and	balanced	heterologous	expression	with	yeast	as	host.	Nonetheless,	there	are	a	
few	 challenges	 which	 must	 be	 met	 for	 broader	 applications.	 For	 the	 purpose	 of	




screening,	by	FACS	 for	example.	Another	challenge	 is	 to	 identify	 relevant	genome	
variation(s)	that	contribute	to	the	phenotype	for	the	SCRaMbLEed	mutants.	Since	the	
SCRaMbLE	 process	 is	 completely	 random,	 many	 genome	 rearrangements	 can	 be	
generated	but	not	all	of	them	are	related	to	the	change	of	phenotype.	The	methods	
described	in	this	thesis,	finding	shared	phenotype	and	genotype	among	the	variants	
and	 testing	 with	 gene	 complementation	 experiments,	 provide	 basic	 strategies	 to	
narrow	 down	 the	modified	 genotype.	 However,	 it	 is	 not	 guaranteed	 that	 shared	
phenotype	and	genotype	will	always	be	captured	and	the	chance	is	even	lower	if	the	
phenotype	 results	 from	comprehensive	 impacts	 from	multiple	 genome	variations.	
Therefore,	 systems	 biology	 analysis,	 computational	 methods	 and	 multi-omics	
approaches	(Chae,	Choi,	Kim,	Ko,	&	Lee,	2017)	must	be	developed	for	analyzing	the	
genotype-phenotype	 relationship,	 which	 will	 help	 us	 to	 better	 understand	 the	
interaction	between	the	heterologous	pathway	and	the	local	metabolism	to	facilitate	
future	rational	design	of	novel	artificial	chromosomes.	There	are	also	some	technical	
issues	 to	 be	 pointed	 out.	 One	 problem	 to	 be	 further	 optimized	 is	 the	 off-target	
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loss	 rate	of	Ura3	 containing	plasmids	during	 counter-selection,	 since	 if	 the	URA3-
containing	marker	 is	not	 lost,	even	the	pathway-integrated	strains	will	not	survive	
and	the	integration	efficiency	can	be	therefore	compromised.	A	modified	version	of	
the	 SCRaMbLE-in	 device	 was	 designed	 to	 eliminate	 URA3	 expression	 after	 Cre-
mediated	recombination	by	placing	the	loxPsym	sites	between	the	promoter	and	ORF	
of	the	Ura3	expression	unit	(Figure	7.1).	If	excision	happens	between	the	two	loxPsym	
sites,	 the	 promoter	 and	 CDS	 of	 the	URA3	 expression	 cassette	 will	 be	 separated,	
thereby	stopping	the	transcription	of	the	Ura3	gene;	if	inversion	happens,	the	second	
promoter	on	the	other	side	of	the	loxPsym	will	still	enable	the	transcription	of	Ura3	









and	 VCre,	 the	 recombination	 orthogonality,	 excision	 efficiency	 and	 integration	





the	 same	strategy.	The	 integration	efficiency	was	 improved	3-fold	with	a	 loxJT15-
loxJTZ17	mutant	pair,	while	its	integration	efficiency	tested	in	E.	coli	was	1500-fold	






the	 tyrosine	 recombinases.	 If	 in	 future	 the	 integration	 efficiency	 could	 be	 raised	
sufficiently,	 multiple	 gene	 regulation	 by	 promoter	 integration	 can	 be	 achieved	









SynNP	 collaborative	 project	 provides	 a	 platform	 to	 express	 and	 engineer	 novel	
synthetic	pathways	in	yeast	for	the	discovery	of	new	antibiotics	against	tuberculosis.	
On	 top	 of	 the	 two	 demonstration	 pathways,	 violacein	 and	 b-carotene,	 I	 further	
	 -	208	-	
worked	on	more	pathway	types	including	the	Nocathiacin	I	pathway	from	the	RiPPs	
class.	A	modular,	 hierarchical	 assembly	workflow	with	 alternative	BsaI	 and	BsmBI	
Golden	Gate	assembly	and	yeast	in	vivo	assembly	was	developed	to	flexibly	construct	
pathways	of	theoretically	any	size	and	gene	numbers.	This	also	enables	combinatorial	
assembly	 of	 the	 promoter,	 terminator	 and	 BSG	 libraries.	 With	 the	 standardized	
workflow,	the	50Kb	Nocathiacin	 I	pathway	with	29	TUs	was	assembled	to	the	YAC	
vector	in	yeast.	Though	the	pathway	has	not	shown	antibiotic	activity	against	the	two	
gram-positive	 strains	 used	 in	 testing,	 the	 on-going	 transcription	 and	 translation	
examination	 by	 RT-PCR	 and	 western	 blot	 narrowed	 down	 the	 problem	 to	 the	
expression	 of	 three	 key	 genes	 in	 the	 pathway,	 and	 further	 optimization	 and	
engineering	on	these	genes	can	be	carried	out	to	deal	with	the	problem.	In	addition	
to	the	strategy	of	combinatorial	assembly,	the	recombinase-based	in	vivo	and	in	vitro	
toolkit	 can	 also	 be	 applied	 for	 optimizing	 antibiotic	 production	 by	 pathway	 and	
chassis	level	evolution.	For	example,	the	in	vitro	recombination	system	can	be	used	
to	 switch	 tailoring	 enzyme	 expression	 units	 or	 BSG	 clusters	 for	 the	 purpose	 of	
chemical	diversification.	As	 to	 the	screening	strategy,	 the	cell-based	overlay	assay	
currently	 serves	 well	 for	 selecting	 variants	 with	 antibiotic	 activity	 regardless	 of	
whether	 the	 target	 chemical	 has	 color	 or	 odor.	 However,	 one	 condition	 for	 the	
overlay	 assay	 is	 that	 the	 yield	 of	 the	 antibiotic	 has	 to	 reach	 the	 MIC	 (minimal	
inhibition	concentration)	and	those	with	yield	below	the	MIC	will	not	be	detected.	
Therefore,	more	sensitive	methods	for	detecting	yeast	variants	with	negative	if	not	
lethal	 effect	 on	 the	 test	 pathogens	 are	 necessary	 for	 the	 initial	 screening	 of	 new	
antibiotics.	 Subsequent	 optimization	 can	 be	 performed	 to	 further	 improve	 the	





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Name	 Type	 Marker	 Source	
pRS413	 Yeast Centromere plasmids (YCp) HIS3	 Cai	Lab	
pRS415	 Yeast Centromere plasmids (YCp) LEU2	 Cai	Lab	
pRS416	 Yeast Centromere plasmids (YCp) URA3	 Cai	Lab	
pRS423	 Yeast Episomal plasmids (YEp) HIS3	 Cai	Lab	
 
Bacteria	plasmids	
Name	 Type	 Marker	 Source	











HCKan_P	 GGCT	 GATG	 Promoter	assembly	
HCKan_O	 GATG	 TAGC	 ORF	assembly	
HCKan_T	 TAGC	 CCTC	 Terminator	assembly	
POT1	 ACCT	 TGAG	 1	TU	assembly		
POT2	 ACCT	 AGGC	 >1	TU	assembly	
POT3	 AGGC	 TGAG	 2	TUs	assembly	
POT4	 AGGC	 TGCC	 >2	TUs	assembly	
POT5	 TGCC	 TGAG	 3	TUs	assembly	
POT6	 TGCC	 CACT	 >3	TUs	assembly	
POT7	 CACT	 TGAG	 4	TUs	assembly	
POT8	 CACT	 GTCG	 >4	TUs	assembly	
POT9	 GTCG	 TGAG	 5	TUs	assembly	
POT10	 GTCG	 GGAG	 >5	TUs	assembly	
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